Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer, January 2019

Free Subscription


Retrieve all available abstracts of the following 508 articles:
HTML format


Single Articles

  1. PRENDEVILLE S, Berney DM, Bubendorf L, Comperat E, et al
    Handling and Reporting of Pelvic Lymphadenectomy Specimens in Prostate and Bladder Cancer: A Web-based Survey by the European Network of Uropathologists (ENUP).
    Histopathology. 2019 Jan 3. doi: 10.1111/his.13818.
    Abstract     Related articles   

  2. SJODAHL G, Jackson Chelsea L, Bartlett J, Robert SD, et al
    Molecular Profiling In Muscle Invasive Bladder Cancer: More Than The Sum Of Its Parts.
    J Pathol. 2019 Jan 2. doi: 10.1002/path.5230.
    Abstract     Related articles   

  3. STUBENDORFF B, Wilhelm K, Posselt K, Catto J, et al
    A three-gene methylation marker panel for the nodal metastatic risk assessment of muscle-invasive bladder cancer.
    J Cancer Res Clin Oncol. 2019 Jan 2. pii: 10.1007/s00432-018-02829.
    Abstract     Related articles   

  4. VAN OSCH FHM, Vlaanderen J, Jochems SHJ, Bosetti C, et al
    Modeling the complex exposure history of smoking in predicting bladder cancer: a pooled analysis of 15 case-control studies.
    Epidemiology. 2018 Dec 26. doi: 10.1097/EDE.0000000000000964.
    Abstract     Related articles   

  5. TOKUNAGA K, Furuta A, Arizono S, Teramoto Y, et al
    Duodenal obstruction induced by retroperitoneal progression of bladder cancer: a report of two cases.
    Abdom Radiol (NY). 2019 Jan 1. pii: 10.1007/s00261-018-1874.
    Abstract     Related articles   

  6. GALLIOLI A, Boissier R, Territo A, Breda A, et al
    Towards the future of upper tract urothelial carcinoma surveillance: lessons learnt from bladder cancer urinary biomarkers.
    World J Urol. 2019 Jan 2. pii: 10.1007/s00345-018-2611.
    Abstract     Related articles   

  7. ZHANG W, Zhang J, Zhang Z, Guo Y, et al
    Overexpression of Indoleamine 2,3-Dioxygenase 1 Promotes Epithelial-Mesenchymal Transition by Activation of the IL-6/STAT3/PD-L1 Pathway in Bladder Cancer.
    Transl Oncol. 2018;12:485-492.
    Abstract     Related articles   

  8. SMAL MP, Kuzhir TD, Savina NV, Nikitchenko NV, et al
    BER gene polymorphisms associated with key molecular events in bladder cancer.
    Exp Oncol. 2018;40:288-298.
    Abstract     Related articles   

  9. WU CH, Silvers CR, Messing EM, Lee YF, et al
    Bladder cancer extracellular vesicles drive tumorigenesis by inducing the unfolded protein response in endoplasmic reticulum of non-malignant cells.
    J Biol Chem. 2018 Dec 28. pii: RA118.006682. doi: 10.1074/jbc.RA118.006682.
    Abstract     Related articles   

  10. SALMASI A, Elashoff DA, Guo R, Upfill-Brown A, et al
    Urinary cytokine profile to predict response to intravesical BCG with or without HS-410 therapy in patients with non-muscle invasive bladder cancer.
    Cancer Epidemiol Biomarkers Prev. 2018 Dec 28. pii: 1055-9965.EPI-18-0893.
    Abstract     Related articles   

  11. TRIPATHI A, Plimack ER
    Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions.
    Curr Urol Rep. 2018;19:109.
    Abstract     Related articles   

  12. CEANGA AI, Ceanga M, Eveslage M, Herrmann E, et al
    Preoperative anemia and extensive transfusion during stay-in-hospital are critical for patient`s mortality: A retrospective multicenter cohort study of oncological patients undergoing radical cystectomy.
    Transfus Apher Sci. 2018;57:739-745.
    Abstract     Related articles   

  13. RODRIGUEZ-VIDA A, Bellmunt J
    Avelumab for the treatment of urothelial cancer.
    Expert Rev Anticancer Ther. 2018;18:421-429.
    Abstract     Related articles   

  14. CHEN A, Chong J, Si Q, Haines K, et al
    Robotic approach to resection of villous adenoma of the urachus: a case report and literature review.
    J Robot Surg. 2018;12:567-570.
    Abstract     Related articles   

  15. HUANG CJ, Lee CH, Chang YH, Won JG, et al
    Paravesical (urachal) paraganglioma (PGL) presenting as hypertensive crisis during micturition, mimicking bladder PGL.
    J Formos Med Assoc. 2018;117:247-249.
    Abstract     Related articles   

  16. ONISHI T, Sekito S, Shibahara T, Uchida K, et al
    The role of continuous saline bladder irrigation after transurethral resection in patients with high-grade non-muscle-invasive bladder cancer.
    Scand J Urol. 2019 Jan 10:1-4. doi: 10.1080/21681805.2018.1548502.
    Abstract     Related articles   

  17. CHEN R, Zhou X, Liu J, Huang G, et al
    Relationship between the expression of PD-1/PD-L1 and (18)F-FDG uptake in bladder cancer.
    Eur J Nucl Med Mol Imaging. 2019 Jan 9. pii: 10.1007/s00259-018-4208.
    Abstract     Related articles   

  18. MATUSZEWSKI M, Szymanska B, Dlugosz A, Malkiewicz B, et al
    Preliminary Evaluation of the Diagnostic Usefulness of Uroplakin 2 with an Assessment of the Antioxidant Potential of Patients with Bladder Cancer.
    Biomed Res Int. 2018;2018:8693297.
    Abstract     Related articles   

  19. ELMUSSAREH M, Simonsen PC, Young M, Kingo PS, et al
    Correlation between organ-specific co-morbidities and complications in bladder cancer patients undergoing radical cystectomy.
    Scand J Urol. 2019 Jan 9:1-6. doi: 10.1080/21681805.2018.1531921.
    Abstract     Related articles   

    Population-based validation of the National Comprehensive Cancer Network recommendations for baseline imaging for bladder cancer: a case for routine baseline bone scan?
    J Comp Eff Res. 2019 Jan 9. doi: 10.2217/cer-2018-0113.
    Abstract     Related articles   

  21. NASRAZADANI M, Maracy MR, Dreassi E, Mahaki B, et al
    Mapping of Stomach, Colorectal, and Bladder Cancers in Iran, 2004-2009: Applying Bayesian Polytomous Logit Model.
    Int J Prev Med. 2018;9:104.
    Abstract     Related articles   

  22. DANIELSSON G, Malmstrom PU, Jahnson S, Wijkstrom H, et al
    Bladder health in patients treated with BCG instillations for T1G2-G3 bladder cancer - a follow-up five years after the start of treatment.
    Scand J Urol. 2019 Jan 8:1-8. doi: 10.1080/21681805.2018.1538162.
    Abstract     Related articles   

  23. WANG JR, Liu B, Zhou L, Huang YX, et al
    MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
    Cancer Biomark. 2018 Dec 27. pii: CBM182000. doi: 10.3233/CBM-182000.
    Abstract     Related articles   

  24. ZHANG LF, Ren KW, Zuo L, Zou JG, et al
    VEGF gene rs3025039C/T and rs833052C/A variants are associated with bladder cancer risk in Asian descendants.
    J Cell Biochem. 2019 Jan 4. doi: 10.1002/jcb.28324.
    Abstract     Related articles   

  25. CHEN JB, Zhu YW, Guo X, Yu C, et al
    Microarray expression profiles analysis revealed lncRNA OXCT1-AS1 promoted bladder cancer cell aggressiveness via miR-455-5p/JAK1 signaling.
    J Cell Physiol. 2019 Jan 4. doi: 10.1002/jcp.28037.
    Abstract     Related articles   

  26. RYU H, Jin H, Ho JN, Bae J, et al
    Suberoylanilide Hydroxamic Acid Can Re-sensitize a Cisplatin-Resistant Human Bladder Cancer.
    Biol Pharm Bull. 2019;42:66-72.
    Abstract     Related articles   

  27. WANG L, Xin F, Lin N, Wang Y, et al
    Metallothioneins may be a potential prognostic biomarker for tumors: A Prisma-compliant meta-analysis.
    Medicine (Baltimore). 2018;97:e13786.
    Abstract     Related articles   

  28. WANG K, Zhou H, Lu Y, Lu Q, et al
    ALK-negative urachal inflammatory myofibroblastic tumor in an elderly female: A case report.
    Medicine (Baltimore). 2018;97:e13619.
    Abstract     Related articles   

  29. ZHOU Y, Guan H, Fu Y, Mao L, et al
    The impact of pre-existing cancer on survival of prostate cancer patients: A population-based study.
    Medicine (Baltimore). 2018;97:e13479.
    Abstract     Related articles   

  30. YUK HD, Kim JK, Jeong CW, Kwak C, et al
    Differences in Pathologic Results of Repeat Transurethral Resection of Bladder Tumor (TURBT) according to Institution Performing the Initial TURBT: Comparative Analyses between Referred and Nonreferred Group.
    Biomed Res Int. 2018;2018:9432606.
    Abstract     Related articles   

  31. TUNG MC, Wen YC, Wang SS, Lin YW, et al
    Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population.
    Int J Med Sci. 2018;15:1187-1193.
    Abstract     Related articles   

  32. PAVONE C, Candela L, Fontana D, Simonato A, et al
    Postoperative complications and 90-day mortality in radical cystectomy in high-risk patients: A monocentric retrospective observational study.
    Urologia. 2018;85:111-117.
    Abstract     Related articles   

  33. FANG T, Liu DD, Ning HM, Dan Liu, et al
    Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3.
    Acta Pharmacol Sin. 2018;39:1885-1893.
    Abstract     Related articles   

  34. MCGRATH JS, Daneshmand S
    Readmission Following Radical Cystectomy: A Ray of Light in the "Black Box"?
    Eur Urol Focus. 2018;4:718-719.
    Abstract     Related articles   

  35. SILVA-SMITH R, Sussman DA
    Co-occurrence of Lynch syndrome and juvenile polyposis syndrome confirmed by multigene panel testing.
    Fam Cancer. 2018;17:87-90.
    Abstract     Related articles   

  36. BAO F, Deng Y, Dai Q
    ACID: Association Correction for Imbalanced Data in GWAS.
    IEEE/ACM Trans Comput Biol Bioinform. 2018;15:316-322.
    Abstract     Related articles   

  37. PALMISANO F, Gadda F, Spinelli MG, Maggioni M, et al
    Symplastic glomus tumor of the urinary bladder treated by robot-assisted partial cystectomy: a case report and literature review.
    Urologia. 2018;85:130-132.
    Abstract     Related articles   

  38. AMARA CS, Ambati CR, Vantaku V, Piyarathna DWB, et al
    Serum metabolic profiling identified a distinct metabolic signature in Bladder Cancer Smokers: A key metabolic enzymes associated with patient survival.
    Cancer Epidemiol Biomarkers Prev. 2019 Jan 14. pii: 1055-9965.EPI-18-0936.
    Abstract     Related articles   

  39. MONTEIRO-REIS S, Lobo J, Henrique R, Jeronimo C, et al
    Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  40. XIE X, Pan J, Han X, Chen W, et al
    Downregulation of microRNA-532-5p promotes the proliferation and invasion of bladder cancer cells through promotion of HMGB3/Wnt/beta-catenin signaling.
    Chem Biol Interact. 2019 Jan 10. pii: S0009-2797(18)31262.
    Abstract     Related articles   

  41. MOROZUMI K, Mitsuzuka K, Takai Y, Katsumata Y, et al
    Intraoperative hypothermia is a significant prognostic predictor of radical cystectomy especially for stage II muscle-invasive bladder cancer.
    Medicine (Baltimore). 2019;98:e13962.
    Abstract     Related articles   

  42. LIU Y, Wu X, Wang G, Hu S, et al
    CALD1, CNN1, and TAGLN identified as potential prognostic molecular markers of bladder cancer by bioinformatics analysis.
    Medicine (Baltimore). 2019;98:e13847.
    Abstract     Related articles   

  43. CRITSELIS E, Rava M, Marquez M, Lygirou V, et al
    Diagnostic and prognostic performance of Secreted Protein Acidic and Rich in Cysteine (SPARC) assay for detecting primary and recurrent urinary bladder cancer.
    Proteomics Clin Appl. 2019 Jan 11:e1800148. doi: 10.1002/prca.201800148.
    Abstract     Related articles   

  44. WUJANTO C, Tey J, Chia D, Ho F, et al
    Radical radiotherapy in older patients with muscle invasive bladder cancer.
    J Geriatr Oncol. 2019 Jan 7. pii: S1879-4068(18)30302.
    Abstract     Related articles   

  45. NIWA N, Matsumoto K, Ide H
    The clinical implication of gamma globulin levels in patients with nonmuscle-invasive bladder cancer.
    Urol Oncol. 2019 Jan 7. pii: S1078-1439(18)30552.
    Abstract     Related articles   

  46. SONG D, Jiao W, Gao Z, Liu N, et al
    Inflammatory myofibroblastic tumor of urinary bladder with severe hematuria: A Case report and literature review.
    Medicine (Baltimore). 2019;98:e13987.
    Abstract     Related articles   

    Bladder Cancer Treatment (PDQ(R)): Patient Version
    Bull Cancer. 2018;105 Suppl 1:S43-S49.
    Abstract     Related articles   

  48. HUANG Z, Xiao H, Lu X, Yan W, et al
    Enhanced photo/chemo combination efficiency against bladder tumor by encapsulation of DOX and ZnPC into in situ-formed thermosensitive polymer hydrogel.
    Int J Nanomedicine. 2018;13:7623-7631.
    Abstract     Related articles   

  49. KHAN FM, Gupta SK, Wolkenhauer O
    Integrative workflows for network analysis.
    Essays Biochem. 2018;62:549-561.
    Abstract     Related articles   

  50. DENG J, Peng M, Wang Z, Zhou S, et al
    Novel application of metformin combined with targeted drugs on anticancer treatment.
    Cancer Sci. 2019;110:23-30.
    Abstract     Related articles   

  51. BOSSERMAN AJ, Dai D, Lu Y
    Imaging Characteristics of a Bladder Wall Paraganglioma.
    Clin Nucl Med. 2019;44:66-67.
    Abstract     Related articles   

  52. DELAUNE T, Bernard F, Matres-Lorenzo L, Bernarde A, et al
    Radical cystectomy and subsequent ureterohysterostomy in a bitch.
    Vet Surg. 2018;47:1106-1111.
    Abstract     Related articles   

  53. ELAWDY MM, Osman Y, Taha DE, El-Halwagy S, et al
    Coincidental Bladder Cuff Transitional Cell Carcinoma in Nephroureterectomy Specimens: Risk Factors, Prognosis and Clinical Implementation.
    Urol J. 2018;15:256-260.
    Abstract     Related articles   

  54. XU Z, Zhang Q, Luh F, Jin B, et al
    Overexpression of the ASPM gene is associated with aggressiveness and poor outcome in bladder cancer.
    Oncol Lett. 2019;17:1865-1876.
    Abstract     Related articles   

  55. LU JJ, Su YW, Wang CJ, Li DF, et al
    Semaphorin 4D promotes the proliferation and metastasis of bladder cancer by activating the PI3K/AKT pathway.
    Tumori. 2019 Jan 24:300891618811280. doi: 10.1177/0300891618811280.
    Abstract     Related articles   

  56. RAJA SA, Abbas S, Shah STA, Tariq A, et al
    Increased expression levels of Syntaxin 1A and Synaptobrevin 2/Vesicle-Associated Membrane Protein-2 are associated with the progression of bladder cancer.
    Genet Mol Biol. 2019 Jan 21:0. doi: 10.1590/1678-4685-GMB-2017-0339.
    Abstract     Related articles   

  57. GUO CC, Czerniak B
    Bladder Cancer in the Genomic Era.
    Arch Pathol Lab Med. 2019 Jan 23. doi: 10.5858/arpa.2018-0329.
    Abstract     Related articles   

  58. QIU F, Zhang MR, Zhou Z, Pu JX, et al
    lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    J Cell Biochem. 2019 Jan 22. doi: 10.1002/jcb.28373.
    Abstract     Related articles   

  59. GUPTA M, Milbar N, Tema G, Pederzoli F, et al
    Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology.
    World J Urol. 2019 Jan 23. pii: 10.1007/s00345-018-02624.
    Abstract     Related articles   

  60. YEE CH, Zheng Z, Shuman L, Yamashita H, et al
    Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS.
    Sci Rep. 2019;9:270.
    Abstract     Related articles   

  61. TAARNHOJ GA, Johansen C, Pappot H
    Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature.
    Health Qual Life Outcomes. 2019;17:20.
    Abstract     Related articles   

  62. RODRIGUES D, Pinto J, Araujo AM, Jeronimo C, et al
    GC-MS Metabolomics Reveals Distinct Profiles of Low- and High-Grade Bladder Cancer Cultured Cells.
    Metabolites. 2019;9.
    Abstract     Related articles   

  63. DAGA M, Pizzimenti S, Dianzani C, Cucci MA, et al
    Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
    Phytomedicine. 2018;56:156-164.
    Abstract     Related articles   

  64. AMR S, Wolpert BJ, St George DM, James I, et al
    Body mass index modifies bladder cancer risk associated with low estrogen exposure among Egyptian women after menopause.
    Cancer Causes Control. 2019 Jan 21. pii: 10.1007/s10552-019-1131.
    Abstract     Related articles   

  65. WANG F, Chen HG, Zhang RY, Jin D, et al
    Diffusion kurtosis imaging to assess correlations with clinicopathologic factors for bladder cancer: a comparison between the multi-b value method and the tensor method.
    Eur Radiol. 2019 Jan 21. pii: 10.1007/s00330-018-5977.
    Abstract     Related articles   

  66. GIRARD A, Rouanne M, Taconet S, Radulescu C, et al
    Integrated analysis of (18)F-FDG PET/CT improves preoperative lymph node staging for patients with invasive bladder cancer.
    Eur Radiol. 2019 Jan 21. pii: 10.1007/s00330-018-5959.
    Abstract     Related articles   

  67. BLACK P, Gontero P
    SIU-ICUD consultation on bladder cancer 2018.
    World J Urol. 2019 Jan 21. pii: 10.1007/s00345-018-2601.
    Abstract     Related articles   

  68. ZHAO S, Xie Q, Yang R, Wang J, et al
    High prevalence of secondary bladder cancer in men on radiotherapy for prostate cancer: evidence from a meta-analysis.
    Cancer Manag Res. 2019;11:587-598.
    Abstract     Related articles   

  69. WU J, Li W, Ning J, Yu W, et al
    Long noncoding RNA UCA1 targets miR-582-5p and contributes to the progression and drug resistance of bladder cancer cells through ATG7-mediated autophagy inhibition.
    Onco Targets Ther. 2019;12:495-508.
    Abstract     Related articles   

  70. MIERZEJEWSKA P, Gawlik-Jakubczak T, Jablonska P, Czajkowski M, et al
    Nicotinamide metabolism alterations in bladder cancer: Preliminary studies.
    Nucleosides Nucleotides Nucleic Acids. 2019.
    Abstract     Related articles   

  71. JIN S, Wang B, Zhu Y, Dai W, et al
    Log Odds Could Better Predict Survival in Muscle-Invasive Bladder Cancer Patients Compared with pN and Lymph Node Ratio.
    J Cancer. 2019;10:249-256.
    Abstract     Related articles   

  72. CHEN Z, Chen X, Xie R, Huang M, et al
    DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression.
    Mol Ther. 2019 Jan 9. pii: S1525-0016(19)30004.
    Abstract     Related articles   

  73. FU YR, Chen F, Luo Y, Yi YF, et al
    Nanoscale bubble ultrasound contrast agents-mediated suicide gene therapy system, Nanoscale bubble-LV5-YCD-TK/GCV/5-FC, effectively inhibits bladder cancer cell growth.
    Eur Rev Med Pharmacol Sci. 2019;23:75-86.
    Abstract     Related articles   

  74. KWAN ML, Kushi LH, Danforth KN, Roh JM, et al
    The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer.
    Cancer Causes Control. 2019 Jan 17. pii: 10.1007/s10552-019-1130.
    Abstract     Related articles   

  75. WANG X, Wang H, Song Y
    Clinical efficacy and mechanism of Pralatrexate combined with Palbociclib Isethionate in treatment of bladder cancer patients.
    Oncol Lett. 2019;17:201-208.
    Abstract     Related articles   

  76. YE G, Kan S, Chen J, Lu X, et al
    Puerarin in inducing apoptosis of bladder cancer cells through inhibiting SIRT1/p53 pathway.
    Oncol Lett. 2019;17:195-200.
    Abstract     Related articles   

  77. HOU Y
    MiR-506 inhibits cell proliferation, invasion, migration and epithelial-to-mesenchymal transition through targeting RWDD4 in human bladder cancer.
    Oncol Lett. 2019;17:73-78.
    Abstract     Related articles   

  78. EISSA S, Safwat M, Matboli M, Zaghloul A, et al
    Measurement of Urinary Level of a Specific Competing endogenous RNA network (FOS and RCAN mRNA/ miR-324-5p, miR-4738-3p, /lncRNA miR-497-HG) Enables Diagnosis of Bladder Cancer.
    Urol Oncol. 2019 Jan 14. pii: S1078-1439(18)30518.
    Abstract     Related articles   

  79. FURUYA H, Chan OTM, Pagano I, Zhu C, et al
    Effectiveness of two different dose administration regimens of an IL-15 superagonist complex (ALT-803) in an orthotopic bladder cancer mouse model.
    J Transl Med. 2019;17:29.
    Abstract     Related articles   

  80. MISTRETTA FA, Carrion DM, Nazzani S, Vasquez JL, et al
    Bladder recurrence of primary upper tract urinary carcinoma following nephro-ureterectomy, and risk of upper urinary tract recurrence after ureteral stent positioning in patients with primary bladder cancer: a contemporary non-systematic review of the
    Minerva Urol Nefrol. 2019 Jan 17. pii: S0393-2249.19.03311.
    Abstract     Related articles   

  81. DUNN JA, Jefferson K, MacDonald D, Iqbal G, et al
    J Steroid Biochem Mol Biol. 2019 Jan 14. pii: S0960-0760(18)30620.
    Abstract     Related articles   

  82. RUSSO V, Roperto F, Taulescu M, De Falco F, et al
    Expression of the feline leukemia virus subgroup C receptors in normal and neoplastic urothelium of the urinary bladder of cattle associated with bovine papillomavirus infection.
    Vet Microbiol. 2019;229:147-152.
    Abstract     Related articles   

  83. KRASNOW RE, Rodriguez D, Nagle RT, Mossanen M, et al
    The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
    Urol Oncol. 2018;36:500.
    Abstract     Related articles   

  84. YAP SA, Brunson A, Pugashetti N, M P H RDC, et al
    Immediate intravesical chemotherapy for low-grade bladder tumors in California: An underutilized practice and its impact on recurrence.
    Urol Oncol. 2018;36:498.
    Abstract     Related articles   

  85. COX RM, Magi-Galluzzi C, McKenney JK
    Immunohistochemical Pitfalls in Genitourinary Pathology: 2018 Update.
    Adv Anat Pathol. 2018;25:387-399.
    Abstract     Related articles   

  86. WHONGSIRI P, Pimratana C, Wijitsettakul U, Sanpavat A, et al
    Oxidative stress and LINE-1 reactivation in bladder cancer are epigenetically linked through active chromatin formation.
    Free Radic Biol Med. 2019 Jan 28. pii: S0891-5849(18)32321.
    Abstract     Related articles   

  87. ANDREW AS, Karagas MR, Schroeck FR, Marsit CJ, et al
    MicroRNA dysregulation and non-muscle invasive bladder cancer prognosis.
    Cancer Epidemiol Biomarkers Prev. 2019 Jan 30. pii: 1055-9965.EPI-18-0884.
    Abstract     Related articles   

  88. RAVEN PA, D'Costa NM, Moskalev I, Tan Z, et al
    Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) model.
    Am J Clin Exp Urol. 2018;6:245-259.
    Abstract     Related articles   

  89. MENG XY, Shi MJ, Zeng ZH, Chen C, et al
    The Role of COL5A2 in Patients With Muscle-Invasive Bladder Cancer: A Bioinformatics Analysis of Public Datasets Involving 787 Subjects and 29 Cell Lines.
    Front Oncol. 2019;8:659.
    Abstract     Related articles   

  90. DOMINGOS-PEREIRA S, Sathiyanadan K, La Rosa S, Polak L, et al
    Intravesical Ty21a vaccine promotes dendritic cells and T cell-mediated tumor regression in the MB49 bladder cancer model.
    Cancer Immunol Res. 2019 Jan 29. pii: 2326-6066.CIR-18-0671.
    Abstract     Related articles   

  91. FONT A, Luque R, Villa JC, Domenech M, et al
    The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG).
    Target Oncol. 2019 Jan 29. pii: 10.1007/s11523-019-00619.
    Abstract     Related articles   

  92. RAMAKRISHNAN S, Granger V, Rak M, Hu Q, et al
    Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer.
    Cell Death Differ. 2019 Jan 28. pii: 10.1038/s41418-019-0278.
    Abstract     Related articles   

  93. VISNJAR T, Romih R, Zupancic D
    Lectins as possible tools for improved urinary bladder cancer management.
    Glycobiology. 2019 Jan 25. pii: 5301307. doi: 10.1093.
    Abstract     Related articles   

  94. SHI S, Tian B
    Identification of biomarkers associated with progression and prognosis in bladder cancer via co-expression analysis.
    Cancer Biomark. 2019 Jan 18. pii: CBM181940. doi: 10.3233/CBM-181940.
    Abstract     Related articles   

    Penile Implant Considerations in the Bladder Cancer Survivor.
    Curr Urol Rep. 2019;20:7.
    Abstract     Related articles   

  96. BIELLI P, Di Stasi SM, Sette C
    The emerging role of PTBP1 in human cancer: novel prognostic factor in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  97. PATHAK RA, Hemal AK
    Frailty and sarcopenia impact surgical and oncologic outcomes after radical cystectomy in patients with bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  98. SORIA F, Shariat SF
    Biomarkers for the prediction of oncologic outcomes in non-muscle invasive bladder cancer: state of affairs and new frontiers.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

    Does robotic radical cystectomy impede oncological outcome in bladder cancer patients?
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  100. PICHLER R, Loidl W, Pichler M
    High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  101. KAAG MG, Raman JD
    Sarcopenia is a reliable predictor of outcomes following radical cystectomy for bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  102. BATURA D
    Redefining the role of immediate intravesical instillation of mitomycin C in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  103. AJIB K, Kulkarni GS
    Editorial comment: bladder preservation as a treatment strategy in muscle-invasive bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

    Do we have all the facts to determine the impact of bacillus Calmette-Guerin therapy on bladder cancer?
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  105. LEE KH, Ku JH
    Targeting splicing factors as molecular non-muscle invasive bladder cancer predictors.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  106. DAL MORO F, Colicchia M
    Does obesity impact bladder cancer prognosis?-a long-lasting debate.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  107. OOSTERLINCK W, Decaestecker K
    An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancers.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

    The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  109. BRODIE A, McCauley N, Cresswell J, Vasdev N, et al
    T1G3 bladder cancer, bacillus Calmette-Guerin and radical cystectomy: continued debate.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  110. ROSSER CJ
    Nutritional implications for quality of life in bladder cancer survivors.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  111. JIANG DM, Jiang H, Chung PWM, Zlotta AR, et al
    Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019;17:38-45.
    Abstract     Related articles   

  112. ABDELRAHMAN AE, Rashed HE, Elkady E, Elsebai EA, et al
    Fatty acid synthase, Her2/neu, and E2F1 as prognostic markers of progression in non-muscle invasive bladder cancer.
    Ann Diagn Pathol. 2019;39:42-52.
    Abstract     Related articles   

  113. LEOW JJ, Bedke J, Chamie K, Collins JW, et al
    SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer.
    World J Urol. 2019 Jan 25. pii: 10.1007/s00345-018-2606.
    Abstract     Related articles   

  114. LORENZATTI HILES G, Cates AL, El-Sawy L, Day KC, et al
    A surgical orthotopic approach for studying the invasive progression of human bladder cancer.
    Nat Protoc. 2019 Jan 25. pii: 10.1038/s41596-018-0112.
    Abstract     Related articles   

  115. BLACK PC, Goebell PJ, Kamat AM, Nawroth R, et al
    Editorial: Basic research in bladder cancer - refining the tools. 3rd IBCN seminars series(1).
    Urol Oncol. 2019 Jan 22. pii: S1078-1439(19)30003.
    Abstract     Related articles   

  116. CHEN L, Long Y, Han Z, Yuan Z, et al
    MicroRNA-101 inhibits cell migration and invasion in bladder cancer via targeting FZD4.
    Exp Ther Med. 2019;17:1476-1485.
    Abstract     Related articles   

  117. WANG Y, Xu Z, Wang X
    miRNA-373 promotes urinary bladder cancer cell proliferation, migration and invasion through upregulating epidermal growth factor receptor.
    Exp Ther Med. 2019;17:1190-1195.
    Abstract     Related articles   

  118. CHO SK, Su LJ, Mao C, Wolenski CD, et al
    Multifunctional nanoclusters of NaYF4:Yb(3+),Er(3+) upconversion nanoparticle and gold nanorod for simultaneous imaging and targeted chemotherapy of bladder cancer.
    Mater Sci Eng C Mater Biol Appl. 2019;97:784-792.
    Abstract     Related articles   

  119. HA YS, Kim SW, Chun SY, Chung JW, et al
    Association between De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) and oncological outcomes in bladder cancer patients after radical cystectomy.
    BMC Urol. 2019;19:10.
    Abstract     Related articles   

  120. [Expert consensus on treatment of intravesical therapy in non-muscle invasive bladder cancer].
    Zhonghua Zhong Liu Za Zhi. 2019;41:42-45.
    Abstract     Related articles   

  121. ZHOU J, Yang C, Lu Z, Zhang L, et al
    Primary urothelial carcinoma of the prostate: A rare case report.
    Medicine (Baltimore). 2019;98:e14155.
    Abstract     Related articles   

  122. TONG S, Yang Z, Zu X, Li Y, et al
    Anterior versus posterior approach laparoscopic radical cystectomy: a retrospective analysis.
    World J Surg Oncol. 2019;17:9.
    Abstract     Related articles   

  123. MARTINI T, Heinkele J, Mayr R, Weis CA, et al
    Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy.
    Urol Oncol. 2018;36:530.
    Abstract     Related articles   

  124. LALANI AA, Sonpavde GP
    Systemic treatments for metastatic urothelial carcinoma.
    Expert Opin Pharmacother. 2019;20:201-208.
    Abstract     Related articles   

  125. GU YQ, Shen WY, Zhou Y, Chen SF, et al
    A pyrazolopyrimidine based fluorescent probe for the detection of Cu(2+) and Ni(2+) and its application in living cells.
    Spectrochim Acta A Mol Biomol Spectrosc. 2019;209:141-149.
    Abstract     Related articles   

  126. RIVA G, Mian C, Luchini C, Girolami I, et al
    Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis.
    Virchows Arch. 2019;474:13-20.
    Abstract     Related articles   

  127. MILLER R, Heinlen JE
    Reported rates of clostridium difficile following radical cystectomy in national datasets compared to individual institutions.
    Urol Oncol. 2018;36:526.
    Abstract     Related articles   

  128. MURAKAMI M, Kiyota H, Kasai K, Bando S, et al
    Antimicrobial prophylaxis for transurethral resection of bladder tumor: A retrospective comparison of preoperative single-dose administration of piperacillin and tazobactam/piperacillin.
    J Infect Chemother. 2018;24:954-957.
    Abstract     Related articles   

  129. LI CY, Dai YX, Chen YJ, Chu SY, et al
    Cancer Risks in Vitiligo Patients: A Nationwide Population-Based Study in Taiwan.
    Int J Environ Res Public Health. 2018;15.
    Abstract     Related articles   

  130. KONG V, Taylor A, Chung P, Rosewall T, et al
    Evaluation of resource burden for bladder adaptive strategies: A timing study.
    J Med Imaging Radiat Oncol. 2018;62:861-865.
    Abstract     Related articles   

  131. ADHYA AK, Pradhan MR
    Ectopic prostatic tissue presenting as a mucosal tumor in urinary bladder.
    Indian J Pathol Microbiol. 2018;61:452-453.
    Abstract     Related articles   

  132. LEFFLER AJ, Hostnik ET, Warry EE, Habing GG, et al
    Canine urinary bladder transitional cell carcinoma tumor volume is dependent on imaging modality and measurement technique.
    Vet Radiol Ultrasound. 2018;59:767-776.
    Abstract     Related articles   

  133. BURGER M
    Editorial Commentary on Gregers et al.
    Scand J Urol. 2018;52:199.
    Abstract     Related articles   

  134. MARQUEEN KE, Waingankar N, Sfakianos JP, Mehrazin R, et al
    Early Mortality in Patients With Muscle-Invasive Bladder Cancer Undergoing Cystectomy in the United States.
    JNCI Cancer Spectr. 2018;2:pky075.
    Abstract     Related articles   

  135. JORGENSEN MS, Oldenburg WA, Murray PM
    Mycotic Aneurysm of the Ulnar Artery Secondary to Bacillus Calmette-Guerin Therapy for Bladder Cancer: A Rare Presentation of Hypothenar Hammer Syndrome.
    J Hand Surg Am. 2019 Feb 4. pii: S0363-5023(18)31479.
    Abstract     Related articles   

  136. SOUKUPOVA K, Rudolf E
    Suppression of proliferation and activation of cell death by sodium selenite involves mitochondria and lysosomes in chemoresistant bladder cancer cells.
    J Trace Elem Med Biol. 2019;52:58-67.
    Abstract     Related articles   

  137. MARCQ G, Jarry E, Ouzaid I, Hermieu JF, et al
    Contemporary best practice in the use of neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Ther Adv Urol. 2019;11:1756287218823678.
    Abstract     Related articles   

  138. RAO A, Patel MR
    A review of avelumab in locally advanced and metastatic bladder cancer.
    Ther Adv Urol. 2019;11:1756287218823485.
    Abstract     Related articles   

  139. OSTERMAN CK, Babu DS, Geynisman DM, Lewis B, et al
    Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin-Based Chemotherapy for Muscle-Invasive Bladder Cancer.
    Oncologist. 2019 Feb 6. pii: theoncologist.2018-0561.
    Abstract     Related articles   

  140. DI Y, Chen D, Yu W, Yan L, et al
    Bladder cancer stage-associated hub genes revealed by WGCNA co-expression network analysis.
    Hereditas. 2019;156:7.
    Abstract     Related articles   

  141. ZHANG X, Liu X, Jing Z, Bi J, et al
    The circINTS4/miR-146b/CARMA3 axis promotes tumorigenesis in bladder cancer.
    Cancer Gene Ther. 2019 Feb 6. pii: 10.1038/s41417-019-0085.
    Abstract     Related articles   

  142. BOC A, Crisan N, Vesa SC, Coman I, et al
    The impact of minimal invasive surgery on early complications and mortality after radical cystectomy for muscle-invasive urothelial bladder cancer.
    J BUON. 2018;23:104-110.
    Abstract     Related articles   

  143. SIGNES-PASTOR AJ, Scot Zens M, Seigne J, Schned A, et al
    Rice Consumption and Incidence of Bladder Cancer in the United States Population.
    Epidemiology. 2019;30:e4-e5.
    Abstract     Related articles   

  144. RAPHAEL MJ, Booth CM
    Neoadjuvant chemotherapy for muscle-invasive bladder cancer: Underused across the 49(th) parallel.
    Can Urol Assoc J. 2019;13:29-31.
    Abstract     Related articles   

  145. OGIHARA K, Kikuchi E, Okazaki S, Hagiwara M, et al
    Sulfasalazine may modulate the CD44v9-xCT system and enhance CDDP-induced cytotoxic effects in metastatic bladder cancer.
    Cancer Sci. 2019 Feb 4. doi: 10.1111/cas.13960.
    Abstract     Related articles   

  146. TSAI YS, Jou YC, Tsai HT, Shiau AL, et al
    Prothymosin-alpha Enhances PTEN Expression and Binds with TRIM21 to Regulate Keap1/Nrf2 Signaling in Human Bladder Cancer.
    Cancer Sci. 2019 Feb 4. doi: 10.1111/cas.13963.
    Abstract     Related articles   

  147. HEIDE T, Maurer A, Eipel M, Knoll K, et al
    Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapy.
    J Pathol. 2019 Feb 4. doi: 10.1002/path.5250.
    Abstract     Related articles   

  148. LEMKE EA, Shah AY
    Management of Advanced Bladder Cancer: An Update.
    J Adv Pract Oncol. 2018;9:410-416.
    Abstract     Related articles   

  149. XU C, Zhou J, Wang Y, Wang A, et al
    Inhibition of malignant human bladder cancer phenotypes through the down-regulation of the long non-coding RNA SNHG7.
    J Cancer. 2019;10:539-546.
    Abstract     Related articles   

  150. CHEN Y, Liu L, Guo Z, Wang Y, et al
    Lost expression of cell adhesion molecule 1 is associated with bladder cancer progression and recurrence and its overexpression inhibited tumor cell malignant behaviors.
    Oncol Lett. 2019;17:2047-2056.
    Abstract     Related articles   

  151. COTRUVO JA, Amato H
    National Trends of Bladder Cancer and Trihalomethanes in Drinking Water: A Review and Multicountry Ecological Study.
    Dose Response. 2019;17:1559325818807781.
    Abstract     Related articles   

  152. LIU YN, Zhang H, Zhang L, Cai TT, et al
    Sphingosine 1 phosphate receptor-1 (S1P1) promotes tumor-associated regulatory T cell expansion: leading to poor survival in bladder cancer.
    Cell Death Dis. 2019;10:50.
    Abstract     Related articles   

    Editorial comment on: The role of continuous saline bladder irrigation after transurethral resection in patients with high-grade non-muscle-invasive bladder cancer.
    Scand J Urol. 2019 Feb 4:1-2. doi: 10.1080/21681805.2018.1563629.
    Abstract     Related articles   

  154. HU G, Wang X, Han Y, Wang P, et al
    Protein arginine methyltransferase 5 promotes bladder cancer growth through inhibiting NF-kB dependent apoptosis.
    EXCLI J. 2018;17:1157-1166.
    Abstract     Related articles   

  155. PAK S, You D, Jeong IG, Song C, et al
    Induction Chemotherapy Followed by Surgery Versus Upfront Radical Cystectomy in Patients With Clinically Node-positive Muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019 Jan 9. pii: S1558-7673(19)30008.
    Abstract     Related articles   

  156. AL-DAGHMIN A, Alhamss S, Al-Najjar H, Al-Saidi I, et al
    Survival and metastasis in muscle-invasive bladder cancer patients who present with indeterminate pulmonary nodules before treatment.
    Ann Saudi Med. 2019;39:42-47.
    Abstract     Related articles   

  157. MINA S, Pardo Munevar CA, Osorio D, Garcia-Perdomo HA, et al
    Life quality evaluation in patients with bladder cancer: A systematic review.
    Actas Urol Esp. 2019 Jan 30. pii: S0210-4806(18)30230.
    Abstract     Related articles   

  158. SAFWAT O, Abd-Ellatif RN, Othman TS, Afifi M, et al
    The evolving role of protein disulfide isomerase A3 in Egyptian bladder cancer patients.
    Gene. 2019 Jan 29. pii: S0378-1119(19)30068-X. doi: 10.1016/j.gene.2019.
    Abstract     Related articles   

  159. ISHII A, Tei Y, Murakami T, Notohara K, et al
    An unusual case of Abeta2M amyloid deposition in bladder cancer in a non-dialysis patient.
    Pathol Int. 2019 Feb 1. doi: 10.1111/pin.12770.
    Abstract     Related articles   

  160. BOSSCHIETER J, Nieuwenhuijzen JA, Hentschel A, van Splunter AP, et al
    A two-gene methylation signature for the diagnosis of bladder cancer in urine.
    Epigenomics. 2019 Feb 1. doi: 10.2217/epi-2018-0094.
    Abstract     Related articles   

  161. KATTEPUR AK, Patkar S, Goel M, Ramaswamy A, et al
    Role of Adjuvant Chemotherapy in Resected T2N0 Gall Bladder Cancer.
    J Gastrointest Surg. 2019 Jan 31. pii: 10.1007/s11605-019-04104.
    Abstract     Related articles   

  162. YUK HD, Jeong CW, Kwak C, Kim HH, et al
    Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting.
    Front Oncol. 2019;8:642.
    Abstract     Related articles   

  163. YANG X, Zhao L, Zhang T, Xi J, et al
    Protosappanin B promotes apoptosis and causes G1 cell cycle arrest in human bladder cancer cells.
    Sci Rep. 2019;9:1048.
    Abstract     Related articles   

  164. MATULAY JT, Woldu SL, Lim A, Narayan VM, et al
    The impact of squamous histology on survival in patients with muscle-invasive bladder cancer.
    Urol Oncol. 2019 Jan 28. pii: S1078-1439(19)30021.
    Abstract     Related articles   

  165. BURKHARD FC, Thalmann GN
    No survival benefit with extended lymphadenectomy: now what?
    Nat Rev Urol. 2019;16:3-4.
    Abstract     Related articles   

  166. KONG V, Kwan M, Chen S, Chung P, et al
    Quantification of interobserver variability in image registration using conebeam CT for partial bladder radiotherapy - A Comparison between Lipiodol and Bladder Wall Surface.
    Br J Radiol. 2018 Nov 1:20180413. doi: 10.1259/bjr.20180413.
    Abstract     Related articles   

  167. FROEHNER M, Koch R, Hubler M, Heberling U, et al
    Predicting 90-day and long-term mortality in octogenarians undergoing radical cystectomy.
    BMC Urol. 2018;18:91.
    Abstract     Related articles   

  168. ELKADY N, Sultan M, Elkhouly E
    Evaluation of topoisomerase II, ki-67, and P53 expression in non-muscle-invasive urothelial carcinoma and their clinical significance.
    Indian J Pathol Microbiol. 2018;61:526-531.
    Abstract     Related articles   

  169. ADIL K, Popovic M, Cury FL, Faria SL, et al
    Anisotropic Bladder Planning Target Volume in Bladder Radiation Therapy.
    Pract Radiat Oncol. 2019;9:24-28.
    Abstract     Related articles   

  170. REDMAN JM, Madan RA
    Spotlight on atezolizumab and its potential as an oncology agent.
    Expert Rev Anticancer Ther. 2018;18:719-722.
    Abstract     Related articles   

  171. FREIFELD Y, Krabbe LM, Clinton TN, Woldu SL, et al
    Therapeutic strategies for upper tract urothelial carcinoma.
    Expert Rev Anticancer Ther. 2018;18:765-774.
    Abstract     Related articles   

  172. LIU K, Sun E, Lei M, Li L, et al
    BCG-induced formation of neutrophil extracellular traps play an important role in bladder cancer treatment.
    Clin Immunol. 2019 Feb 13. pii: S1521-6616(18)30633.
    Abstract     Related articles   

  173. MONTALBO R, Lozano JJ, Izquierdo L, Ingelmo-Torres M, et al
    Ability of a urine gene expression classifier to reduce the number of follow-up cystoscopies in bladder cancer patients.
    Transl Res. 2019 Feb 7. pii: S1931-5244(19)30025.
    Abstract     Related articles   

  174. WITZKE KE, Grosserueschkamp F, Jutte H, Horn M, et al
    Integrated Fourier Transform Infrared Imaging and Proteomics for Identification of a Candidate Histochemical Biomarker in Bladder Cancer.
    Am J Pathol. 2019 Feb 9. pii: S0002-9440(18)30739.
    Abstract     Related articles   

  175. OEYEN E, Hoekx L, De Wachter S, Baldewijns M, et al
    Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  176. CHUNG J, Kulkarni GS, Morash R, Matthew A, et al
    Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory.
    Support Care Cancer. 2019 Feb 14. pii: 10.1007/s00520-019-4649.
    Abstract     Related articles   

  177. SIDDIQUI MR, Railkar R, Sanford T, Crooks DR, et al
    Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT).
    Sci Rep. 2019;9:2084.
    Abstract     Related articles   

  178. CAO YP, Sun JY, Li MQ, Dong Y, et al
    Inhibition of G9a by a small molecule inhibitor, UNC0642, induces apoptosis of human bladder cancer cells.
    Acta Pharmacol Sin. 2019 Feb 14. pii: 10.1038/s41401-018-0205.
    Abstract     Related articles   

  179. KULKARNI GS, Black PC, Sridhar SS, Kapoor A, et al
    Canadian Urological Association guideline: Muscle-invasive bladder cancer.
    Can Urol Assoc J. 2019 Jan 31. pii: cuaj.5902. doi: 10.5489/cuaj.5902.
    Abstract     Related articles   

  180. LIN T, Jin H, Gong L, Yu R, et al
    Surveillance of non-muscle invasive bladder cancer using fluorescence in situ hybridization: Protocol for a systematic review and meta-analysis.
    Medicine (Baltimore). 2019;98:e14573.
    Abstract     Related articles   

  181. KISPERT S, Marentette J, McHowat J
    Cigarette smoking promotes bladder cancer via increased platelet-activating factor.
    Physiol Rep. 2019;7:e13981.
    Abstract     Related articles   

  182. WU S, Ou T, Xing N, Lu J, et al
    Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer.
    Nat Commun. 2019;10:720.
    Abstract     Related articles   

  183. DENG S, He SY, Zhao P, Zhang P, et al
    The role of oncostatin M receptor gene polymorphisms in bladder cancer.
    World J Surg Oncol. 2019;17:30.
    Abstract     Related articles   

  184. MAJ M, Kokocha A, Bajek A, Drewa T, et al
    The effects of adipose-derived stem cells on CD133-expressing bladder cancer cells.
    J Cell Biochem. 2019 Feb 11. doi: 10.1002/jcb.28436.
    Abstract     Related articles   

  185. DENG Y, Bi R, Guo H, Yang J, et al
    Andrographolide Enhances TRAIL-Induced Apoptosis via p53-Mediated Death Receptors Up-Regulation and Suppression of the NF-small ka, CyrillicB Pathway in Bladder Cancer Cells.
    Int J Biol Sci. 2019;15:688-700.
    Abstract     Related articles   

  186. SU Y, Yang W, Jiang N, Shi J, et al
    Hypoxia-elevated circELP3 contributes to bladder cancer progression and cisplatin resistance.
    Int J Biol Sci. 2019;15:441-452.
    Abstract     Related articles   

  187. XIE R, Chen X, Chen Z, Huang M, et al
    Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.
    Cancer Lett. 2019 Feb 8. pii: S0304-3835(19)30071.
    Abstract     Related articles   

  188. KOSOVA IV, Loran OB, Sinyakova LA, Gundorova LV, et al
    [A prognostic value of level of antiviral antibodies in the development of recurrence of bladder cancer].
    Urologiia. 2018;:86-94.
    Abstract     Related articles   

  189. STONE L
    Treatment timing well tolerated in bladder cancer.
    Nat Rev Urol. 2019 Feb 11. pii: 10.1038/s41585-019-0162.
    Abstract     Related articles   

  190. ELIZALDE BENITO FX, Ucar Terren A, Monzon Alebesque F, Urra Palos M, et al
    Bladder cancer with Indian ink.
    Arch Esp Urol. 2019;72:89-90.
    Abstract     Related articles   

  191. GOMEZ RIVAS J, Eguibar Gonzalez A, Tortolero Blanco L, Aguilera Bazan A, et al
    [Usefulness of photodynamic diagnosis in high-grade Bladder Cancer and subsequent BCG failure. Bibliographic review.]
    Arch Esp Urol. 2019;72:2-8.
    Abstract     Related articles   

  192. EINSTEIN DJ, Sonpavde G
    Treatment Approaches for Cisplatin-Ineligible Patients with Invasive Bladder Cancer.
    Curr Treat Options Oncol. 2019;20:12.
    Abstract     Related articles   

  193. WITLOX WJA, van Osch FHM, Brinkman M, Jochems S, et al
    An inverse association between the Mediterranean diet and bladder cancer risk: a pooled analysis of 13 cohort studies.
    Eur J Nutr. 2019 Feb 8. pii: 10.1007/s00394-019-01907.
    Abstract     Related articles   

  194. IMAI Y, Noda S, Matsuyama C, Shimizu A, et al
    Sex steroid hormone receptors in bladder cancer: Usefulness in differential diagnosis and implications in histogenesis of bladder cancer.
    Urol Oncol. 2019 Feb 6. pii: S1078-1439(19)30024.
    Abstract     Related articles   

  195. KRAJEWSKI W, Zdrojowy R, Kolodziej A
    Purified protein derivative skin test-One swallow does not make a summer: Re: Purified protein derivative skin test reactions are associated with clinical outcomes of patients with nonmuscle invasive bladder cancer treated with induction Bacillus Calm
    Urol Oncol. 2019 Feb 5. pii: S1078-1439(19)30025.
    Abstract     Related articles   

  196. OZAWA M, Suenaga S, Ishii T, Suzuki H, et al
    Nihon Hinyokika Gakkai Zasshi. 2018;109:45-49.
    Abstract     Related articles   

  197. ITO A, Takata R, Matsuo T, Kimura T, et al
    Nihon Hinyokika Gakkai Zasshi. 2018;109:35-39.
    Abstract     Related articles   

  198. MITA K, Kobatake K, Ohara S, Kato M, et al
    Nihon Hinyokika Gakkai Zasshi. 2018;109:1-6.
    Abstract     Related articles   

  199. LEE YL, Lai CR, Yen MS
    Recurrent ovarian mixed germ cell tumor with unusual malignant transformation: a case report.
    J Ovarian Res. 2019;12:2.
    Abstract     Related articles   

  200. WANG B, Pan W, Yang M, Yang W, et al
    Programmed death ligand-1 is associated with tumor infiltrating lymphocytes and poorer survival in urothelial cell carcinoma of the bladder.
    Cancer Sci. 2019;110:489-498.
    Abstract     Related articles   

  201. PABO-CARRASCO S, Vallejo-Benitez A, Carmona-Pinelo E, Umbria-Jimenez S, et al
    [Nested variant Transitional Cell Carcinoma. Report of two cases and bibliographic review.]
    Arch Esp Urol. 2018;71:794-799.
    Abstract     Related articles   

  202. KONDO E, Maki S, Nii M, Yoshida K, et al
    Long-term survival of a patient with malignant transformation of extragonadal endometriosis treated solely with chemotherapy: A case report.
    J Obstet Gynaecol Res. 2018;44:2186-2189.
    Abstract     Related articles   

  203. CLEMENTS MB, Krupski TL, Culp SH
    Robotic-Assisted Surgery for Upper Tract Urothelial Carcinoma: A Comparative Survival Analysis.
    Ann Surg Oncol. 2018;25:2550-2562.
    Abstract     Related articles   

  204. CRISCUOLO D, Morra F, Giannella R, Visconti R, et al
    New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment.
    J Exp Clin Cancer Res. 2019;38:91.
    Abstract     Related articles   

  205. KUMAR S, Bhoriwal S, Muduly D, Kar M, et al
    Multimodality management of incidentally detected gall bladder cancer: long term results from a tertiary care cancer centre.
    J Gastrointest Oncol. 2019;10:128-133.
    Abstract     Related articles   

  206. KARATZAS A, Tzortzis V
    Lower urinary tract symptoms and bladder cancer in children: The hidden scenario.
    Urol Ann. 2019;11:102-104.
    Abstract     Related articles   

  207. KALLIFATIDIS G, Smith DK, Morera DS, Gao J, et al
    beta-Arrestins regulate stem cell-like phenotype and response to chemotherapy in bladder cancer.
    Mol Cancer Ther. 2019 Feb 20. pii: 1535-7163.MCT-18-1167.
    Abstract     Related articles   

  208. MORRA F, Merolla F, Criscuolo D, Insabato L, et al
    CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer.
    J Exp Clin Cancer Res. 2019;38:90.
    Abstract     Related articles   

  209. YU H, Wang S, Zhu H, Rao D, et al
    LncRNA MT1JP functions as a tumor suppressor via regulating miR-214-3p expression in bladder cancer.
    J Cell Physiol. 2019 Feb 20. doi: 10.1002/jcp.28274.
    Abstract     Related articles   

  210. RACIOPPI M, Di Gianfrancesco L, Ragonese M, Palermo G, et al
    Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?
    Int Braz J Urol. 2018;45.
    Abstract     Related articles   

  211. XU X, You K, Wu B
    Zonula occludens-1 associated nucleic acid binding protein plays an invasion-promoting role in bladder cancer.
    Neoplasma. 2019 Feb 14. pii: 180725N530. doi: 10.4149/neo_2018_180725.
    Abstract     Related articles   

  212. SHADPOUR P, Zamani M, Aghaalikhani N, Rashtchizadeh N, et al
    Inflammatory cytokines in bladder cancer.
    J Cell Physiol. 2019 Feb 18. doi: 10.1002/jcp.28252.
    Abstract     Related articles   

  213. HU J, Zhou L, Song Z, Xiong M, et al
    The identification of new biomarkers for bladder cancer: A study based on TCGA and GEO datasets.
    J Cell Physiol. 2019 Feb 18. doi: 10.1002/jcp.28208.
    Abstract     Related articles   

  214. LI J, Wang AS, Wang S, Wang CY, et al
    LncSNHG14 promotes the development and progression of bladder cancer by targeting miRNA-150-5p.
    Eur Rev Med Pharmacol Sci. 2019;23:1022-1029.
    Abstract     Related articles   

  215. CAO HL, Liu ZJ, Huang PL, Yue YL, et al
    lncRNA-RMRP promotes proliferation, migration and invasion of bladder cancer via miR-206.
    Eur Rev Med Pharmacol Sci. 2019;23:1012-1021.
    Abstract     Related articles   

  216. KRAJEWSKI W, Rodriguez Faba O, Poletajew S, Palou J, et al
    New predictive nomograms for non-muscle-invasive bladder cancer: it is all about the details.
    World J Urol. 2019 Feb 18. pii: 10.1007/s00345-019-02680.
    Abstract     Related articles   

  217. TAN Y, Zhang T, Zhou L, Liu S, et al
    MiR-34b-3p Represses the Multidrug-Chemoresistance of Bladder Cancer Cells by Regulating the CCND2 and P2RY1 Genes.
    Med Sci Monit. 2019;25:1323-1335.
    Abstract     Related articles   

  218. CHERUKU RR, Cacaccio J, Durrani F, Tabaczynski WA, et al
    Epidermal Growth Factor Receptor Targeted Multifunctional Photosensitizers for Bladder Cancer Imaging and Photodynamic Therapy.
    J Med Chem. 2019 Feb 18. doi: 10.1021/acs.jmedchem.8b01927.
    Abstract     Related articles   

  219. LI S, Zhu Y, Liang Z, Wang X, et al
    Correction: Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer.
    Oncotarget. 2019;10:684.
    Abstract     Related articles   

  220. AMARA CS, Vantaku V, Lotan Y, Putluri N, et al
    Recent advances in the metabolomic study of bladder cancer.
    Expert Rev Proteomics. 2019 Feb 16. doi: 10.1080/14789450.2019.1583105.
    Abstract     Related articles   

  221. ZHANG G, Ma F, Li L, Li J, et al
    Palbociclib triggers apoptosis in bladder cancer cells by Cdk2-induced Rad9-mediated reorganization of the Bak.Bcl-xl complex.
    Biochem Pharmacol. 2019;163:133-141.
    Abstract     Related articles   

  222. SORIA F, Pisano F, Gontero P, Palou J, et al
    Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy.
    World J Urol. 2018;36:1775-1781.
    Abstract     Related articles   

  223. MARGULIS AV, Fortuny J, Kaye JA, Calingaert B, et al
    Value of Free-text Comments for Validating Cancer Cases Using Primary-care Data in the United Kingdom.
    Epidemiology. 2018;29:e41-e42.
    Abstract     Related articles   

  224. SONPAVDE G, Pond GR, Rosenberg JE, Choueiri TK, et al
    Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of Immunotherapy.
    Clin Genitourin Cancer. 2018;16:e961-e967.
    Abstract     Related articles   

  225. HERMANN GG, Mogensen K, Rosthoj S
    Outpatient diode laser treatment of intermediate-risk non-invasive bladder tumors without sedation: efficacy, safety and economic analysis.
    Scand J Urol. 2018;52:194-198.
    Abstract     Related articles   

  226. MENG X, Press B, Renson A, Wysock JS, et al
    Discriminative Ability of Commonly Used Indexes to Predict Adverse Outcomes After Radical Cystectomy: Comparison of Demographic Data, American Society of Anesthesiologists, Modified Charlson Comorbidity Index, and Modified Frailty Index.
    Clin Genitourin Cancer. 2018;16:e843-e850.
    Abstract     Related articles   

  227. HENSLEY PJ, Goodwin J, Davenport DL, Strup SE, et al
    Optimization of Patient Selection for Neoadjuvant Chemotherapy in Muscle-invasive Urothelial Carcinoma of the Bladder.
    Clin Genitourin Cancer. 2018;16:e851-e858.
    Abstract     Related articles   

  228. BREYER J, Wirtz RM, Erben P, Worst TS, et al
    High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma.
    Clin Genitourin Cancer. 2018;16:248-256.
    Abstract     Related articles   

  229. LORENTZ CA, Gilbert K, Alemozaffar M, Patil D, et al
    Risk of Readmission After Uncomplicated Hospitalization After Radical Cystectomy.
    Clin Genitourin Cancer. 2018;16:e705-e710.
    Abstract     Related articles   

  230. HEMDAN T, Turker P, Malmstrom PU, Segersten U, et al
    Choline-phosphate cytidylyltransferase-alpha as a possible predictor of survival and response to cisplatin neoadjuvant chemotherapy in urothelial cancer of the bladder.
    Scand J Urol. 2018;52:200-205.
    Abstract     Related articles   

  231. POWLES T, Necchi A, Rosen G, Hariharan S, et al
    Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development.
    Clin Genitourin Cancer. 2018;16:117-129.
    Abstract     Related articles   

  232. LIU ST, Hui G, Mathis C, Chamie K, et al
    The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era.
    Clin Genitourin Cancer. 2018;16:e269-e276.
    Abstract     Related articles   

  233. GUPTA S, Albertson D, Gaston D, Heilbrun ME, et al
    Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System.
    Clin Genitourin Cancer. 2018;16:e373-e382.
    Abstract     Related articles   

  234. MIRSADRAEI L, Hodkoff A, Jones K, Shabaik A, et al
    Serous Carcinoma Mimicking Primary Urothelial Carcinoma on Clinical Evaluation and Pathology: A Potential Diagnostic Pitfall.
    Arch Pathol Lab Med. 2018;142:168-177.
    Abstract     Related articles   

  235. PEDERSEN M, Stafoggia M, Weinmayr G, Andersen ZJ, et al
    Is There an Association Between Ambient Air Pollution and Bladder Cancer Incidence? Analysis of 15 European Cohorts.
    Eur Urol Focus. 2018;4:113-120.
    Abstract     Related articles   

  236. DO NASCIMENTO ALVES SIPM, Lavalhegas Hallack M, Moreira Perez M, da Costa Aguiar Alves B, et al
    Application of the Z-scan technique for the detection of CFCDNA (cell-free circulating DNA) and urine DNA (uDNA) in patients with bladder cancer.
    Photodiagnosis Photodyn Ther. 2019 Feb 26. pii: S1572-1000(18)30338.
    Abstract     Related articles   

  237. JIANG G, Huang C, Liao X, Li J, et al
    The RING domain in the anti-apoptotic protein XIAP stabilizes c-Myc protein and preserves anchorage-independent growth of bladder cancer cells.
    J Biol Chem. 2019 Feb 28. pii: RA118.005621. doi: 10.1074/jbc.RA118.005621.
    Abstract     Related articles   

  238. LIN JJ, Huang CC, Su YL, Luo HL, et al
    Proteomics Analysis of Tangeretin-Induced Apoptosis through Mitochondrial Dysfunction in Bladder Cancer Cells.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  239. WU T, Duan X, Hu C, Wu C, et al
    Synthesis and characterization of gold nanoparticles from Abies spectabilis extract and its anticancer activity on bladder cancer T24 cells.
    Artif Cells Nanomed Biotechnol. 2019;47:512-523.
    Abstract     Related articles   

  240. LAZARO M, Gallardo E, Domenech M, Pinto A, et al
    Correction to: SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).
    Clin Transl Oncol. 2019 Feb 26. pii: 10.1007/s12094-019-02061.
    Abstract     Related articles   

  241. MATULAY JT, Narayan VM, Kamat AM
    Clinical and Genomic Considerations for Variant Histology in Bladder Cancer.
    Curr Oncol Rep. 2019;21:23.
    Abstract     Related articles   

  242. CHOI JB, Kim JH, Hong SH, Han KD, et al
    Association of body mass index with bladder cancer risk in men depends on abdominal obesity.
    World J Urol. 2019 Feb 26. pii: 10.1007/s00345-019-02690.
    Abstract     Related articles   

  243. LIN JH, Chen SJ, Liu H, Yan Y, et al
    Vitamin E consumption and the risk of bladder cancer.
    Int J Vitam Nutr Res. 2019 Feb 26:1-8. doi: 10.1024/0300-9831/a000553.
    Abstract     Related articles   

  244. TURKER P, Segersten U, Malmstrom PU, Hemdan T, et al
    Is Bcl-2 a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy?
    Scand J Urol. 2019 Feb 26:1-6. doi: 10.1080/21681805.2019.1575467.
    Abstract     Related articles   

  245. DATOVO JCF, Neto WA, Mendonca GB, Andrade DL, et al
    Prognostic impact of non-adherence to follow-up cystoscopy in non-muscle-invasive bladder cancer (NMIBC).
    World J Urol. 2019 Feb 25. pii: 10.1007/s00345-019-02697.
    Abstract     Related articles   

  246. BOERI L, Soligo M, Frank I, Boorjian SA, et al
    Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience.
    World J Urol. 2019 Feb 25. pii: 10.1007/s00345-019-02689.
    Abstract     Related articles   

  247. GURUNG PMS, Barnett AR, Wilson JS, Hudson J, et al
    Prognostic DNA Methylation Biomarkers in High-risk Non-muscle-invasive Bladder Cancer: A Systematic Review to Identify Loci for Prospective Validation.
    Eur Urol Focus. 2019 Feb 22. pii: S2405-4569(19)30032.
    Abstract     Related articles   

  248. CHIANG CH, Chung JG, Hsu FT
    Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF-kappaB-modulated tumor progression in bladder cancer in vitro and in vivo.
    Environ Toxicol. 2019 Feb 25. doi: 10.1002/tox.22734.
    Abstract     Related articles   

  249. MEHTALA J, Khanfir H, Bennett D, Ye Y, et al
    Pioglitazone use and risk of bladder cancer: a systematic literature review and meta-analysis of observational studies.
    Diabetol Int. 2018;10:24-36.
    Abstract     Related articles   

  250. POLETAJEW S, Fus L, Ilczuk T, Wojcieszak P, et al
    Expression of E-cadherin, beta-catenin, and epithelial membrane antigen does not predict survival in patients with high-risk non-muscle-invasive bladder cancer.
    Cent Eur J Immunol. 2018;43:421-427.
    Abstract     Related articles   

  251. BALAKRISHNAN AS, Washington SL 3rd, Meng MV, Porten SP, et al
    Determinants of Guideline-Based Treatment in Patients With cT1 Bladder Cancer.
    Clin Genitourin Cancer. 2019 Jan 19. pii: S1558-7673(19)30018.
    Abstract     Related articles   

  252. LI Y, Rapkin B, Atkinson TM, Schofield E, et al
    Leveraging Latent Dirichlet Allocation in processing free-text personal goals among patients undergoing bladder cancer surgery.
    Qual Life Res. 2019 Feb 23. pii: 10.1007/s11136-019-02132.
    Abstract     Related articles   

  253. SATHIANATHEN NJ, Fan Y, Jarosek SL, Konety I, et al
    Disparities in Bladder Cancer Treatment and Survival Amongst Elderly Patients with a Pre-existing Mental Illness.
    Eur Urol Focus. 2019 Feb 20. pii: S2405-4569(19)30027.
    Abstract     Related articles   

  254. SHIMIZU N, Hamaide A, Dourcy M, Noel S, et al
    Evaluation of urinary and serum level of chemokine (C-C motif) ligand 2 as a potential biomarker in canine urothelial tumours.
    Vet Comp Oncol. 2019;17:11-20.
    Abstract     Related articles   

  255. AHSAINI M, Ouattar K, Azelmad H, Mellas S, et al
    A rare pure embryonal rhabdomyosarcoma of the urinary bladder in an adult successfully managed with neoadjuvant chemotherapy and surgery: a case report.
    J Med Case Rep. 2018;12:329.
    Abstract     Related articles   

  256. TALAT Z, Onal B, Cetinel B, Demirdag C, et al
    The surgical technique and initial outcomes of Anatolian neobladder: a novel technique of ileal neobladder after radical cystectomy.
    BMC Urol. 2018;18:94.
    Abstract     Related articles   

  257. JIN L, Wang M, Yang F, Niu Y, et al
    Surgical techniques for facilitating laparoscopic intracorporeal orthotopic neobladder: initial experience.
    Int Braz J Urol. 2018;44:1156-1165.
    Abstract     Related articles   

  258. FOGAZZI GB, Delanghe J
    Microscopic examination of urine sediment: Phase contrast versus bright field.
    Clin Chim Acta. 2018;487:168-173.
    Abstract     Related articles   

  259. KALETSCH A, Pinkerneil M, Hoffmann MJ, Jaguva Vasudevan AA, et al
    Effects of novel HDAC inhibitors on urothelial carcinoma cells.
    Clin Epigenetics. 2018;10:100.
    Abstract     Related articles   

  260. FIELDER S, Breshears M
    What is your diagnosis? Bladder mass in a mare.
    Vet Clin Pathol. 2018;47:665-666.
    Abstract     Related articles   

  261. FERSINO S, Arcangeli S, Jereczek-Fossa BA, D'Angelillo R, et al
    GUROPA survey: genito-urinary radiation oncology prescription attitudes.
    Radiol Med. 2018;123:879-884.
    Abstract     Related articles   

  262. JOHANSSON S, Walters R, Mayer K, Shippey S, et al
    Vaginal Myomectomy to Resolve Bladder Outlet Obstruction 50 Years After Hysterectomy.
    Female Pelvic Med Reconstr Surg. 2018;24:e26-e28.
    Abstract     Related articles   

  263. HORI S, Mitsui Y, Suzuki K, Nakajima K, et al
    [Penile Metastasis from Invasive Bladder Carcinoma Diagnosed by Needle Biopsy : A Case Report and Literature Review].
    Hinyokika Kiyo. 2018;64:127-130.
    Abstract     Related articles   

  264. UCHIDA M, Kawai K, Kurobe M, Ikeda A, et al
    [Metastases of Urothelial Carcinoma with Trophoblastic Differentiation that Responded to Combination Chemotherapy with Gemcitabine and Oxaliplatin : A Case Report].
    Hinyokika Kiyo. 2018;64:55-61.
    Abstract     Related articles   

  265. BRETSCHNEIDER CE, Share SM, Paraiso MFR
    Nephrogenic Adenoma in the Setting of Refractory Labial Agglutination in an Elderly Woman.
    Female Pelvic Med Reconstr Surg. 2018;24:e6-e8.
    Abstract     Related articles   

  266. SANFORD T, Meng MV, Railkar R, Agarwal PK, et al
    Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma.
    Clin Epigenetics. 2018;10:19.
    Abstract     Related articles   

  267. BOTELHO F
    Editorial Comment on: Isolated Red Patches Seen During Endoscopic Surveillance of Bladder Cancer: Incidence of Malignancy and When Should We Biopsy? by Nkwam et al.
    J Endourol. 2018;32:328.
    Abstract     Related articles   

  268. HOLSCHER AS, Schulz WA, Pinkerneil M, Niegisch G, et al
    Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines.
    Clin Epigenetics. 2018;10:1.
    Abstract     Related articles   

  269. FERNANDEZ-ACENERO MJ, Perez Alonso P, Diaz Del Arco C
    Histiocytic sarcoma with bladder involvement: Case report and literature review.
    Rev Esp Patol. 2018;51:23-26.
    Abstract     Related articles   

  270. HUANG SY, Chien CC, Hseu RS, Huang VYJ, et al
    Ganoderma microsporum immunomodulatory protein induces apoptosis and potentiates mitomycin C-induced apoptosis in urinary bladder urothelial carcinoma cells.
    J Cell Biochem. 2018;119:4592-4606.
    Abstract     Related articles   

  271. SMITH AH, Marshall G, Roh T, Ferreccio C, et al
    Lung, Bladder, and Kidney Cancer Mortality 40 Years After Arsenic Exposure Reduction.
    J Natl Cancer Inst. 2018;110:241-249.
    Abstract     Related articles   

  272. AFSHARPAD M, Nowroozi MR, Mobasheri MB, Ayati M, et al
    Cancer-Testis Antigens as New Candidate Diagnostic Biomarkers for Transitional Cell Carcinoma of Bladder.
    Pathol Oncol Res. 2019;25:191-199.
    Abstract     Related articles   

  273. MOSCHINI M, Morlacco A, Briganti A, Hu B, et al
    Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy.
    Eur Urol Focus. 2018;4:245-251.
    Abstract     Related articles   

  274. VETTERLEIN MW, Seisen T, May M, Nuhn P, et al
    Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
    Eur Urol Focus. 2018;4:252-259.
    Abstract     Related articles   

  275. JOSHI M, Millis SZ, Arguello D, Holder SL, et al
    Molecular Characterization of Bladder Cancer in Smokers versus Nonsmokers.
    Eur Urol Focus. 2018;4:94-97.
    Abstract     Related articles   

  276. COLOMBO R, Hurle R, Moschini M, Freschi M, et al
    Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer.
    Eur Urol Focus. 2018;4:87-93.
    Abstract     Related articles   

  277. OKUBO K, Isono M, Asano T, Sato A, et al
    Metformin Augments Panobinostat's Anti-Bladder Cancer Activity by Activating AMP-Activated Protein Kinase.
    Transl Oncol. 2019;12:669-682.
    Abstract     Related articles   

  278. SONG Y, Yang Y, Liu L, Liu X, et al
    Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: A systematic review and meta-analysis involving 6671 subjects.
    Gene. 2019 Mar 5. pii: S0378-1119(19)30211-2. doi: 10.1016/j.gene.2019.
    Abstract     Related articles   

  279. ZHANG W, Shi L, Zhao Z, Du P, et al
    Disruption of CTLA-4 expression on peripheral blood CD8 + T cell enhances anti-tumor efficacy in bladder cancer.
    Cancer Chemother Pharmacol. 2019 Mar 8. pii: 10.1007/s00280-019-03800.
    Abstract     Related articles   

  280. HOU T, Zhou L, Wang L, Kazobinka G, et al
    Correction: CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway.
    Oncotarget. 2019;10:1010.
    Abstract     Related articles   

  281. FAN J, Wu K, Zhang P, He D, et al
    Green-laser assisted laparoscopic partial cystectomy for selective muscle-invasive bladder cancer: technique and initial outcome.
    World J Urol. 2019 Mar 6. pii: 10.1007/s00345-019-02712.
    Abstract     Related articles   

  282. KONALA VM, Adapa S, Aronow WS
    Immunotherapy in Bladder Cancer.
    Am J Ther. 2019 Feb 28. doi: 10.1097/MJT.0000000000000934.
    Abstract     Related articles   

  283. GOK B, Atmaca AF, Canda AE, Asil E, et al
    Robotic radical cystectomy with intracorporeal Studer pouch formation for bladder cancer: Experience in 98 cases.
    J Endourol. 2019 Mar 6. doi: 10.1089/end.2019.0036.
    Abstract     Related articles   

  284. KIM DK, Lee JY, Jung JH, Hah YS, et al
    Role of adjuvant cisplatin-based chemotherapy following radical cystectomy in locally advanced muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized trials.
    Investig Clin Urol. 2019;60:64-74.
    Abstract     Related articles   

  285. GILD P, Nguyen DD, Fletcher SA, Cole AP, et al
    Contemporary Survival Rates for Muscle-Invasive Bladder Cancer Treated With Definitive or Non-Definitive Therapy.
    Clin Genitourin Cancer. 2019 Jan 29. pii: S1558-7673(19)30036.
    Abstract     Related articles   

  286. TEMRAZ S, Haibe Y, Charafeddine M, Saifi O, et al
    The unveiling of a new risk factor associated with bladder cancer in Lebanon.
    BMC Urol. 2019;19:16.
    Abstract     Related articles   

  287. HUMAYUN-ZAKARIA N, Arnold R, Goel A, Ward D, et al
    Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  288. BABJUK M
    En-bloc resection of non-muscle invasive bladder cancer: what must be answered in the future?
    World J Urol. 2019 Mar 5. pii: 10.1007/s00345-019-02710.
    Abstract     Related articles   

  289. RODRIGUES D, Pinto J, Araujo AM, Monteiro-Reis S, et al
    Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry.
    Metabolomics. 2018;14:62.
    Abstract     Related articles   

  290. LIANG H, Yang T, Wu K, He D, et al
    En bloc resection improves the identification of muscularis mucosae in non-muscle invasive bladder cancer.
    World J Urol. 2019 Mar 4. pii: 10.1007/s00345-019-02672.
    Abstract     Related articles   

  291. SAWICKA E, Kratz EM, Szymanska B, Guzik A, et al
    Preliminary Study on Selected Markers of Oxidative Stress, Inflammation and Angiogenesis in Patients with Bladder Cancer.
    Pathol Oncol Res. 2019 Mar 4. pii: 10.1007/s12253-019-00620.
    Abstract     Related articles   

  292. WANG J, Zhang J, Li T, Shen R, et al
    Strand displacement amplification-coupled dynamic light scattering method to detect urinary telomerase for non-invasive detection of bladder cancer.
    Biosens Bioelectron. 2019;131:143-148.
    Abstract     Related articles   

  293. HUANG C, Liao X, Jin H, Xie F, et al
    MEG3, as a Competing Endogenous RNA, Binds with miR-27a to Promote PHLPP2 Protein Translation and Impairs Bladder Cancer Invasion.
    Mol Ther Nucleic Acids. 2019;16:51-62.
    Abstract     Related articles   

  294. LINDNER AK, Klatte T, Comperat E, Heidegger I, et al
    Therapeutic rationale of targeting BCG and immune checkpoints in non-muscle-invasive bladder cancer: Is this the Future?
    Urol Oncol. 2019 Feb 27. pii: S1078-1439(19)30054.
    Abstract     Related articles   

  295. GIRARD A, Rouanne M
    Comment on: Relationship between the expression of PD-1/PD-L1 and (18)F-FDG uptake in bladder cancer.
    Eur J Nucl Med Mol Imaging. 2019 Mar 1. pii: 10.1007/s00259-019-04296.
    Abstract     Related articles   

  296. BERNDT-PAETZ M, Schulze P, Stenglein PC, Weimann A, et al
    Reduction of muscle-invasive tumors by photodynamic therapy with Tetrahydroporphyrin-Tetratosylat in an orthotopic rat bladder cancer model.
    Mol Cancer Ther. 2019 Mar 1. pii: 1535-7163.MCT-18-1194.
    Abstract     Related articles   

  297. GAO R, Zhang N, Yang J, Zhu Y, et al
    Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-beta1 in bladder cancer cells.
    J Exp Clin Cancer Res. 2019;38:111.
    Abstract     Related articles   

  298. MA Y, Mao G, Zhong Y, Wu G, et al
    Highly sensitive ratiometric fluorescent paper sensor for the urine assay of cancer.
    Talanta. 2019;194:199-204.
    Abstract     Related articles   

  299. MITRA AP, Fairey AS, Skinner EC, Boorjian SA, et al
    Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation.
    Urol Oncol. 2019;37:48-56.
    Abstract     Related articles   

  300. SASAHARA T, Sasaki H, Yoshiyama Y, Kimura S, et al
    [A Case of Urachal Carcinoma Treated with Laparoscopic Resection of Urachal Remnants with Partial Cystectomy that was Difficult to Diagnose Preoperatively by Transurethral Biopsy].
    Hinyokika Kiyo. 2018;64:345-348.
    Abstract     Related articles   

  301. BARNES JL, Zubair M, John K, Poirier MC, et al
    Carcinogens and DNA damage.
    Biochem Soc Trans. 2018;46:1213-1224.
    Abstract     Related articles   

  302. PAI A, Mackie S, Watson G
    Novel use of air in laser ablation of bladder transitional cell carcinoma.
    Ann R Coll Surg Engl. 2019;101:227.
    Abstract     Related articles   

  303. DENIZE J, Bugel H, Bou Nasr E, Delcourt C, et al

    Gynecol Obstet Fertil Senol. 2018;46.
    Abstract     Related articles   

  304. QIN ZJ, Bi H, Ma LL, Huang Y, et al
    [A primary intestinal-derived adenocarcinoma in intestine bladder substitutes: a case report].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2018;50:737-739.
    Abstract     Related articles   

  305. TANG XG, Yan Y, Qiu M, Lu J, et al
    [Retrospective study of young bladder urothelial carcinoma from a single center within 16 years].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2018;50:630-633.
    Abstract     Related articles   

  306. AKHTAR S, Al-Shammari A, Al-Abkal J
    Chronic urinary tract infection and bladder carcinoma risk: a meta-analysis of case-control and cohort studies.
    World J Urol. 2018 Feb 5. pii: 10.1007/s00345-018-2206.
    Abstract     Related articles   

  307. KIM BS, Tae BS, Ku JH, Kwak C, et al
    Rate and association of lower urinary tract infection with recurrence after transurethral resection of bladder tumor.
    Investig Clin Urol. 2018;59:10-17.
    Abstract     Related articles   

  308. CENCINI E, Fabbri A, Schiattone L, Gentili F, et al
    Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma.
    Acta Clin Belg. 2018;73:408-412.
    Abstract     Related articles   

  309. INOUE S, Mizushima T, Miyamoto H
    Role of the androgen receptor in urothelial cancer.
    Mol Cell Endocrinol. 2018;465:73-81.
    Abstract     Related articles   

  310. GIANNOPOULOU AF, Velentzas AD, Konstantakou EG, Avgeris M, et al
    Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  311. STEELE TM, Talbott GC, Sam A, Tepper CG, et al
    Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  312. LUNDBERG E, Hagberg O, Jahnson S, Ljungberg B, et al
    Association between occurrence of urinary bladder cancer and treatment with statin medication.
    Turk J Urol. 2019;45:97-102.
    Abstract     Related articles   

  313. HAIDER M, Ladurner C, Mayr R, Tandogdu Z, et al
    Use and duration of antibiotic prophylaxis and the rate of urinary tract infection after radical cystectomy for bladder cancer: Results of a multicentric series.
    Urol Oncol. 2019 Mar 12. pii: S1078-1439(19)30018.
    Abstract     Related articles   

  314. ZHU J, Li Y, Luo Y, Xu J, et al
    A Feedback Loop Formed by ATG7/Autophagy, FOXO3a/miR-145 and PD-L1 Regulates Stem-Like Properties and Invasion in Human Bladder Cancer.
    Cancers (Basel). 2019;11.
    Abstract     Related articles   

  315. POLETAJEW S, Krajewski W, Adamowicz J, Radziszewski P, et al
    A systematic review of preventive and therapeutic options for symptoms of cystitis in patients with bladder cancer receiving intravesical bacillus Calmette-Guerin immunotherapy.
    Anticancer Drugs. 2019 Mar 11. doi: 10.1097/CAD.0000000000000775.
    Abstract     Related articles   

  316. BAI ZJ, Liu Q, Wang XS, Liu WY, et al
    APC promoter methylation is correlated with development and progression of bladder cancer, but not linked to overall survival: a meta-analysis.
    Neoplasma. 2019 Mar 7. pii: 181009N753. doi: 10.4149/neo_2018_181009.
    Abstract     Related articles   

  317. CHEN J, Cao L, Li Z, Li Y, et al
    SIRT1 promotes GLUT1 expression and bladder cancer progression via regulation of glucose uptake.
    Hum Cell. 2019 Mar 13. pii: 10.1007/s13577-019-00237.
    Abstract     Related articles   

  318. CADIOU S, Al Tabaa O, Nguyen CD, Faccin M, et al
    Back pain following instillations of BCG for superficial bladder cancer is not a reactive complication: review of 30 Mycobacterium bovis BCG vertebral osteomyelitis cases.
    Clin Rheumatol. 2019 Mar 13. pii: 10.1007/s10067-019-04500.
    Abstract     Related articles   

  319. PHILLIPS RM, Loadman PM, Reddy G
    Inactivation of apaziquone by haematuria: implications for the design of phase III clinical trials against non-muscle invasive bladder cancer.
    Cancer Chemother Pharmacol. 2019 Mar 13. pii: 10.1007/s00280-019-03812.
    Abstract     Related articles   

  320. WEN W, Gong J, Wu P, Zhao M, et al
    Mutations in gliclazide-associated genes may predict poor bladder cancer prognosis.
    FEBS Open Bio. 2019;9:457-467.
    Abstract     Related articles   

  321. LIN G, Sheng H, Xie H, Zheng Q, et al
    circLPAR1 is a novel biomarker of prognosis for muscle-invasive bladder cancer with invasion and metastasis by miR-762.
    Oncol Lett. 2019;17:3537-3547.
    Abstract     Related articles   

  322. ALBERTO M, Cuello HA, Gulino CA, Pifano M, et al
    Expression of bladder cancer-associated glycans in murine tumor cell lines.
    Oncol Lett. 2019;17:3141-3150.
    Abstract     Related articles   

  323. WANG Z, Zhou Q, Li A, Huang W, et al
    Extracellular matrix protein 1 (ECM1) is associated with carcinogenesis potential of human bladder cancer.
    Onco Targets Ther. 2019;12:1423-1432.
    Abstract     Related articles   

  324. YANG Y, Wang F, Huang H, Zhang Y, et al
    lncRNA SLCO4A1-AS1 promotes growth and invasion of bladder cancer through sponging miR-335-5p to upregulate OCT4.
    Onco Targets Ther. 2019;12:1351-1358.
    Abstract     Related articles   

  325. SUO N, Wang M, Jin Y, Ding J, et al
    Magnetic multiwalled carbon nanotubes with controlled release of epirubicin: an intravesical instillation system for bladder cancer.
    Int J Nanomedicine. 2019;14:1241-1254.
    Abstract     Related articles   

  326. KLAASSEN Z, Lokeshwar SD, Lowery-Allison A, Wallis CJD, et al
    Mental Illness and Bladder Cancer Patients: The Time for Assertive Intervention Is Now.
    Eur Urol Focus. 2019 Mar 9. pii: S2405-4569(19)30075.
    Abstract     Related articles   

  327. LIM CS, Tirumani S, van der Pol CB, Alessandrino F, et al
    Use of Quantitative T2-Weighted and Apparent Diffusion Coefficient Texture Features of Bladder Cancer and Extravesical Fat for Local Tumor Staging After Transurethral Resection.
    AJR Am J Roentgenol. 2019 Mar 12:1-10. doi: 10.2214/AJR.18.20718.
    Abstract     Related articles   

  328. JOSHUA JM, Vijayan M, Pooleri GK
    A retrospective analysis of patients treated with intravesical BCG for high-risk nonmuscle invasive bladder cancer.
    Ther Adv Urol. 2019;11:1756287219833056.
    Abstract     Related articles   

  329. WANG F, Wu D, Xu Z, Chen J, et al
    miR-182-5p affects human bladder cancer cell proliferation, migration and invasion through regulating Cofilin 1.
    Cancer Cell Int. 2019;19:42.
    Abstract     Related articles   

  330. OUYANG XL, Yang L, Huang L, Pan YM, et al
    Antitumor activity on human bladder cancer T-24 cells and composition analysis of the core of Camellia osmantha fruit.
    Nat Prod Res. 2019 Mar 11:1-5. doi: 10.1080/14786419.2018.1550763.
    Abstract     Related articles   

  331. WU E, Hadjiiski LM, Samala RK, Chan HP, et al
    Deep Learning Approach for Assessment of Bladder Cancer Treatment Response.
    Tomography. 2019;5:201-208.
    Abstract     Related articles   

  332. CHAND D, Dhawan D, Sankin A, Ren X, et al
    Immune Checkpoint B7x (B7-H4/B7S1/VTCN1) is Over Expressed in Spontaneous Canine Bladder Cancer: The First Report and its Implications in a Preclinical Model.
    Bladder Cancer. 2019;5:63-71.
    Abstract     Related articles   

  333. LIU NW, Murray KS, Donat SM, Herr HW, et al
    The Outcome of Post-Chemotherapy Retroperitoneal Lymph Node Dissection in Patients with Metastatic Bladder Cancer in the Retroperitoneum.
    Bladder Cancer. 2019;5:13-19.
    Abstract     Related articles   

  334. AQUILA L, Ohm J, Woloszynska-Read A
    Corrigendum to "The role of STAG2 in bladder cancer" [Pharmacol. Res. 131 (2018) 143-149].
    Pharmacol Res. 2019 Mar 7. pii: S1043-6618(19)30336.
    Abstract     Related articles   

  335. BOORMANS JL, Zwarthoff EC, Black PC, Goebell PJ, et al
    New horizons in bladder cancer research.
    Urol Oncol. 2019 Mar 7. pii: S1078-1439(18)30508.
    Abstract     Related articles   

  336. MARKS P, Gild P, Soave A, Janisch F, et al
    The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy.
    Surg Oncol. 2019;28:208-213.
    Abstract     Related articles   

  337. LI R, Zhang L, Qin Z, Wei Y, et al
    High LINC00536 expression promotes tumor progression and poor prognosis in bladder cancer.
    Exp Cell Res. 2019 Mar 6. pii: S0014-4827(19)30103.
    Abstract     Related articles   

  338. BRANT A, Daniels M, Chappidi MR, Joice GA, et al
    Prognostic implications of prostatic urethral involvement in non-muscle-invasive bladder cancer.
    World J Urol. 2019 Mar 8. pii: 10.1007/s00345-019-02673.
    Abstract     Related articles   

  339. MOSCHINI M, Martini A, Zamboni S, Mattei A, et al
    Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of Surgery.
    Clin Genitourin Cancer. 2019 Feb 13. pii: S1558-7673(19)30045.
    Abstract     Related articles   

  340. SILVERDALE N, Wherry M, Roodhouse A
    Massage and reflexology for post-operative cancer cystectomy patients: Evaluation of a pilot service.
    Complement Ther Clin Pract. 2019;34:109-112.
    Abstract     Related articles   

  341. KIM SC, Park S, Song SH, Kim KS, et al
    Clinicopathological Characteristics of Urinary Bladder Tumors in Korean Patients 20 Years or Younger.
    J Korean Med Sci. 2018;33:e242.
    Abstract     Related articles   

  342. LI P, Ning J, Luo X, Du H, et al
    New method to preserve the original proportion and integrity of urinary cell-free DNA.
    J Clin Lab Anal. 2019;33:e22668.
    Abstract     Related articles   

  343. GE Y, Zhu J, Wang X, Zheng N, et al
    Mapping dynamic histone modification patterns during arsenic-induced malignant transformation of human bladder cells.
    Toxicol Appl Pharmacol. 2018;355:164-173.
    Abstract     Related articles   

  344. SILLS WS, Howerth EW
    Pathology in Practice.
    J Am Vet Med Assoc. 2018;252:1063-1066.
    Abstract     Related articles   

  345. LOERTZER P, Siemer S, Stockle M, Ohlmann CH, et al
    Robot-sewn ileoileal anastomosis during robot-assisted cystectomy.
    World J Urol. 2018;36:1079-1084.
    Abstract     Related articles   

  346. HA YS, Kim SW, Kwon TG, Chung SK, et al
    Decrease in skeletal muscle index 1 year after radical cystectomy as a prognostic indicator in patients with urothelial bladder cancer.
    Int Braz J Urol. 2019;45.
    Abstract     Related articles   

  347. LIAN F, Chen W, Liu Y, Shen L, et al
    Intra-arterial chemotherapy combined with intravesical chemotherapy is effective in preventing recurrence in non-muscle invasive bladder cancer.
    J Cancer Res Clin Oncol. 2019 Mar 21. pii: 10.1007/s00432-019-02900.
    Abstract     Related articles   

  348. FU S, Luan T, Jiang C, Huang Y, et al
    miR-3622a promotes proliferation and invasion of bladder cancer cells by downregulating LASS2.
    Gene. 2019 Mar 18. pii: S0378-1119(19)30247-1. doi: 10.1016/j.gene.2019.
    Abstract     Related articles   

  349. CHEN J, Song B, Kong G
    MicroRNA663b downregulation inhibits proliferation and induces apoptosis in bladder cancer cells by targeting TUSC2.
    Mol Med Rep. 2019 Mar 14. doi: 10.3892/mmr.2019.10023.
    Abstract     Related articles   

  350. BABJUK M
    En-bloc resection of non-muscle invasive bladder cancer: what must be answered in the future?
    World J Urol. 2019 Mar 20. pii: 10.1007/s00345-019-02715.
    Abstract     Related articles   

  351. GUPTA M, Kates M, Bivalacqua TJ
    Immunotherapy in nonmuscle invasive bladder cancer: current and emerging treatments.
    Curr Opin Oncol. 2019 Mar 15. doi: 10.1097/CCO.0000000000000533.
    Abstract     Related articles   

  352. AL KHADER AM, Abu Shahin NI, Obeidat FN, Al-Chalabi MA, et al
    Urinary bladder cancer in Jordanian adults: A histopathological and epidemiological study from a tertiary care center in Amman.
    J Pak Med Assoc. 2019;69:415-417.
    Abstract     Related articles   

  353. YAJIMA S, Yoshida S, Takahara T, Arita Y, et al
    Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progression.
    Eur Radiol. 2019 Mar 19. pii: 10.1007/s00330-019-06119.
    Abstract     Related articles   

  354. HAN Y, Zheng Q, Tian Y, Ji Z, et al
    Identification of a nine-gene panel as a prognostic indicator for recurrence with muscle-invasive bladder cancer.
    J Surg Oncol. 2019 Mar 18. doi: 10.1002/jso.25446.
    Abstract     Related articles   

  355. WALKER AK, Karaszi K, Valentine H, Strauss VY, et al
    MRE11 as a predictive biomarker of outcome following radiotherapy in bladder cancer.
    Int J Radiat Oncol Biol Phys. 2019 Mar 15. pii: S0360-3016(19)30371.
    Abstract     Related articles   

  356. SHAKIBAIE M, Vaezjalali M, Rafii-Tabar H, Sasanpour P, et al
    Synergistic effect of phototherapy and chemotherapy on bladder cancer cells.
    J Photochem Photobiol B. 2019;193:148-154.
    Abstract     Related articles   

  357. AMIR H, Khan MA, Feroz S, Bibi N, et al
    CARLo-7-A plausible biomarker for bladder cancer.
    Int J Exp Pathol. 2019 Mar 18. doi: 10.1111/iep.12305.
    Abstract     Related articles   

  358. HUANG D, Jin YH, Weng H, Huang Q, et al
    Combination of Intravesical Bacille Calmette-Guerin and Chemotherapy vs. Bacille Calmette-Guerin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis.
    Front Oncol. 2019;9:121.
    Abstract     Related articles   

  359. MA J, Sun G, Zhu P, Liu S, et al
    Determination of the complexity and diversity of the TCR beta-chain CDR3 repertoire in bladder cancer using high-throughput sequencing.
    Oncol Lett. 2019;17:3808-3816.
    Abstract     Related articles   

  360. ZHAO H, Bo Q, Wu Z, Liu Q, et al
    KIF15 promotes bladder cancer proliferation via the MEK-ERK signaling pathway.
    Cancer Manag Res. 2019;11:1857-1868.
    Abstract     Related articles   

  361. FAN Z, Liang Y, Yang X, Li B, et al
    A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer.
    Onco Targets Ther. 2019;12:1791-1801.
    Abstract     Related articles   

  362. LEKKA M, Pabijan J, Orzechowska B
    Morphological and mechanical stability of bladder cancer cells in response to substrate rigidity.
    Biochim Biophys Acta Gen Subj. 2019 Mar 13. pii: S0304-4165(19)30060.
    Abstract     Related articles   

  363. LARCHER A, Gandaglia G, Wiklund P, Mottrie A, et al
    Robot-assisted versus open cystectomy in the RAZOR trial.
    Lancet. 2019;393:645.
    Abstract     Related articles   

  364. PAREKH DJ, Venkatramani V
    Robot-assisted versus open cystectomy in the RAZOR trial - Authors' reply.
    Lancet. 2019;393:645-646.
    Abstract     Related articles   

  365. KHETRAPAL P, Catto JWF, Kelly JD
    Robot-assisted versus open cystectomy in the RAZOR trial.
    Lancet. 2019;393:644-645.
    Abstract     Related articles   

  366. DAL MORO F
    Tomorrow (and surgery) never dies.
    Lancet. 2019;393:642-644.
    Abstract     Related articles   

  367. ROCHEL N, Krucker C, Coutos-Thevenot L, Osz J, et al
    Recurrent activating mutations of PPARgamma associated with luminal bladder tumors.
    Nat Commun. 2019;10:253.
    Abstract     Related articles   

  368. ERBEN P, Sikic D, Wirtz RM, Martini T, et al
    Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder.
    Virchows Arch. 2019;474:209-217.
    Abstract     Related articles   

  369. ALTUN E
    MR Imaging of the Urinary Bladder: Added Value of PET-MR Imaging.
    Magn Reson Imaging Clin N Am. 2019;27:105-115.
    Abstract     Related articles   

  370. CHEN YT, Yang CC, Shao PL, Huang CR, et al
    Melatonin-mediated downregulation of ZNF746 suppresses bladder tumorigenesis mainly through inhibiting the AKT-MMP-9 signaling pathway.
    J Pineal Res. 2019;66:e12536.
    Abstract     Related articles   

  371. HAN YS, Kim SM, Lee JH, Jung SK, et al
    Melatonin protects chronic kidney disease mesenchymal stem cells against senescence via PrP(C) -dependent enhancement of the mitochondrial function.
    J Pineal Res. 2019;66:e12535.
    Abstract     Related articles   

  372. AGGARWAL A, Agarwal S, Pandey S, Sankhwar S, et al
    Urachal adenocarcinoma.
    BMJ Case Rep. 2018;2018.
    Abstract     Related articles   

  373. HODGSON A, Liu SK, Vesprini D, Xu B, et al
    Basal-subtype bladder tumours show a 'hot' immunophenotype.
    Histopathology. 2018;73:748-757.
    Abstract     Related articles   

  374. ANDRES-LENCINA JJ, Burillo-Martinez S, Aragon-Miguel R, Calleja-Algarra A, et al
    Eosinophilic fasciitis and lichen sclerosus in a patient treated with nivolumab.
    Australas J Dermatol. 2018;59:e302-e304.
    Abstract     Related articles   

  375. BRIMO F, Downes MR, Jamaspishvili T, Berman D, et al
    Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy.
    Histopathology. 2018;73:732-740.
    Abstract     Related articles   

  376. DELLABELLA M, Branchi A, Gasparri L, Claudini R, et al
    Oncological safety and quality of life in men undergoing simultaneous transurethral resection of bladder tumor and prostate: results from a randomized controlled trial.
    World J Urol. 2018;36:1629-1634.
    Abstract     Related articles   

  377. TAYLOR JM, McTyre ER, Tatter SB, Laxton AW, et al
    Gamma Knife Stereotactic Radiosurgery for the Treatment of Brain Metastases from Primary Tumors of the Urinary Bladder.
    Stereotact Funct Neurosurg. 2018;96:108-112.
    Abstract     Related articles   

  378. RADES D, Sondermann L, Motisi L, Janssen S, et al
    Prognostic Factors and a Survival Score in Patients Irradiated for Metastatic Epidural Spinal Cord Compression from Urothelial Carcinoma Cancer of the Bladder.
    Anticancer Res. 2018;38:6841-6846.
    Abstract     Related articles   

  379. KUSUHARA Y, Daizumoto K, Kawai K, Hirayama K, et al
    Low Expression of Toll-like Receptor 4 Is Associated With Poor Prognosis in Bladder Cancer.
    Anticancer Res. 2019;39:703-711.
    Abstract     Related articles   

  380. VASYUTIN I, Zerihun L, Ivan C, Atala A, et al
    Bladder Organoids and Spheroids: Potential Tools for Normal and Diseased Tissue Modelling.
    Anticancer Res. 2019;39:1105-1118.
    Abstract     Related articles   

  381. KUMAGAI-TOGASHI A, Uozaki H, Kikuchi Y, Watabe S, et al
    Tumorous CD10 Is More Strongly Related to the Progression of Urothelial Carcinoma than Stromal CD10.
    Anticancer Res. 2019;39:635-640.
    Abstract     Related articles   

  382. BOERI L, Soligo M, Frank I, Boorjian SA, et al
    Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle-invasive bladder cancer treated with cisplatin-based neoadjuvant chemotherapy and radical cystectomy: a single-centre expe
    BJU Int. 2019 Jan 8. doi: 10.1111/bju.14612.
    Abstract     Related articles   

  383. BAJIC P, Wolfe AJ, Gupta GN
    Old Instillations and New Implications in Bladder Cancer: The Urinary Microbiome and Intravesical BCG.
    BJU Int. 2019 Jan 21. doi: 10.1111/bju.14683.
    Abstract     Related articles   

  384. D'ANDREA D, Soria F, Zehetmayer S, Gust KM, et al
    Diagnostic accuracy, clinical utility and influence on decision making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer.
    BJU Int. 2019 Jan 17. doi: 10.1111/bju.14673.
    Abstract     Related articles   

  385. TAN WS, Teo CH, Chan D, Heinrich M, et al
    Mix methods approach to explore patients' perspectives on the acceptability of a urinary biomarker test in replacement of cystoscopy in bladder cancer surveillance.
    BJU Int. 2019 Jan 29. doi: 10.1111/bju.14690.
    Abstract     Related articles   

  386. MMEJE CO, Benson CR, Nogueras-Gonzalez GM, Jayaratna IS, et al
    Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy.
    BJU Int. 2018;122:89-98.
    Abstract     Related articles   

  387. JEFFERIES ER, Cresswell J, McGrath JS, Miller C, et al
    Open radical cystectomy in England: the current standard of care - an analysis of the British Association of Urological Surgeons (BAUS) cystectomy audit and Hospital Episodes Statistics (HES) data.
    BJU Int. 2018;121:880-885.
    Abstract     Related articles   

  388. HUGAR LA, Lopa SH, Yabes JG, Yu JA, et al
    Palliative Care Use Among Patients with Bladder Cancer.
    BJU Int. 2019 Feb 13. doi: 10.1111/bju.14708.
    Abstract     Related articles   

  389. BRASSETTI A, Moller A, Laurin O, Hoijer J, et al
    Evolution of cystectomy care over an 11-year period in a high-volume tertiary referral centre.
    BJU Int. 2018;121:752-757.
    Abstract     Related articles   

  390. KIJIMA T, Tanaka H, Koga F, Masuda H, et al
    Selective Tetramodal Bladder Preservation Therapy Incorporating Induction Chemoradiotherapy and Consolidative Partial Cystectomy with Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer: Oncological and Functional Outcomes of 107 Patients.
    BJU Int. 2019 Feb 27. doi: 10.1111/bju.14736.
    Abstract     Related articles   

  391. TARIQ A, Khan SR, Vela I, Williams ED, et al
    Assessment of bladder cancer patients and carers use of internet, social media and quality of available patient centric online resources: A systematic review.
    BJU Int. 2019 Feb 24. doi: 10.1111/bju.14720.
    Abstract     Related articles   

    Postoperative intravesical chemotherapy has an important role in reducing subsequent bladder tumours - why is it not routine?
    BJU Int. 2018;122:525-526.
    Abstract     Related articles   

  393. DUFOUR F, Silina L, Neyret-Kahn H, Moreno-Vega A, et al
    TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer.
    Br J Cancer. 2019 Feb 15. pii: 10.1038/s41416-019-0397.
    Abstract     Related articles   

  394. VANTAKU V, Donepudi SR, Piyarathna DWB, Sekhar Amara C, et al
    Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival.
    Cancer. 2019 Jan 2. doi: 10.1002/cncr.31890.
    Abstract     Related articles   

  395. COLE AP, Fletcher SA, Berg S, Nabi J, et al
    Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?
    Cancer. 2019 Jan 11. doi: 10.1002/cncr.31926.
    Abstract     Related articles   

  396. CHU AT, Holt SK, Wright JL, Ramos JD, et al
    Delays in radical cystectomy for muscle-invasive bladder cancer.
    Cancer. 2019 Mar 6. doi: 10.1002/cncr.32048.
    Abstract     Related articles   

  397. MASIC S, Smaldone MC
    Treatment delays for muscle-invasive bladder cancer.
    Cancer. 2019 Mar 6. doi: 10.1002/cncr.32047.
    Abstract     Related articles   

  398. YU C, Liu Z, Chen Q, Li Y, et al
    Nkx2.8 Inhibits Epithelial-Mesenchymal Transition in Bladder Urothelial Carcinoma via Transcriptional Repression of Twist1.
    Cancer Res. 2018;78:1241-1252.
    Abstract     Related articles   

  399. WANG Z, Cao D, Qi Z, Pang Y, et al
    Retinoic acid-related orphan receptor C regulates proliferation, glycolysis, and chemoresistance via the PD-L1/ITGB6/STAT3 signaling axis in bladder cancer.
    Cancer Res. 2019 Feb 26. pii: 0008-5472.CAN-18-3842.
    Abstract     Related articles   

  400. AVGERIS M, Tsilimantou A, Levis PK, Rampias T, et al
    Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.
    Carcinogenesis. 2019 Feb 27. pii: 5366409. doi: 10.1093.
    Abstract     Related articles   

  401. VANTAKU V, Dong J, Ambati CR, Perera D, et al
    sMulti-omics integration analysis robustly predicts high-grade patient survival and identifies CPT1B effect on fatty acid metabolism in Bladder Cancer.
    Clin Cancer Res. 2019 Mar 7. pii: 1078-0432.CCR-18-1515.
    Abstract     Related articles   

  402. KISS B, van den Berg NS, Ertsey R, McKenna K, et al
    CD47-targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer.
    Clin Cancer Res. 2019 Mar 19. pii: 1078-0432.CCR-18-3267.
    Abstract     Related articles   

  403. NASER-TAVAKOLIAN A, Ghodoussipour S, Djaladat H
    Upper urinary tract recurrence following bladder cancer therapy: a review of surveillance and management.
    Curr Opin Urol. 2019 Feb 11. doi: 10.1097/MOU.0000000000000598.
    Abstract     Related articles   

  404. MUKHERJEE N, Wheeler KM, Svatek RS
    Bacillus Calmette-Guerin treatment of bladder cancer: a systematic review and commentary on recent publications.
    Curr Opin Urol. 2019 Feb 11. doi: 10.1097/MOU.0000000000000595.
    Abstract     Related articles   

  405. MUN DH, Kimura S, Shariat SF, Abufaraj M, et al
    The impact of gender on oncologic outcomes of bladder cancer.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000606.
    Abstract     Related articles   

  406. EULITT PJ, Bjurlin MA, Milowsky MI
    Perioperative systemic therapy for bladder cancer.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000600.
    Abstract     Related articles   

  407. SMELSER WW, Woolbright BL, Taylor JA 3rd
    Molecular subtyping of bladder cancer: current trends and future directions in 2019.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000599.
    Abstract     Related articles   

  408. PHAM A, Ballas LK
    Trimodality therapy for bladder cancer: modern management and future directions.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000601.
    Abstract     Related articles   

  409. BHAT A, Ritch CR
    Urinary biomarkers in bladder cancer: where do we stand?
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000605.
    Abstract     Related articles   

  410. JANISCH F, Shariat SF, Schernhammer E, Rink M, et al
    The interaction of gender and smoking on bladder cancer risks.
    Curr Opin Urol. 2019 Mar 14. doi: 10.1097/MOU.0000000000000602.
    Abstract     Related articles   

  411. CAPURSO G, Archibugi L, Tessieri L, Petrone MC, et al
    Focal immune-related pancreatitis occurring after treatment with programmed cell death 1 inhibitors: a distinct form of autoimmune pancreatitis?
    Eur J Cancer. 2018;95:123-126.
    Abstract     Related articles   

  412. ROUANNE M, Betari R, Radulescu C, Goubar A, et al
    Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer.
    Eur J Cancer. 2019;108:111-119.
    Abstract     Related articles   

  413. NECCHI A, Raggi D, Giannatempo P, Alessi A, et al
    Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure.
    Eur J Cancer. 2018;96:128-130.
    Abstract     Related articles   

  414. GIANNARINI G, Crestani A, Ficarra V
    Re: Stenting Prior to Cystectomy Is an Independent Risk Factor for Upper Urinary Tract Recurrence.
    Eur Urol. 2018;74:395-396.
    Abstract     Related articles   

  415. SZABADOS B, van Dijk N, Tang YZ, van der Heijden MS, et al
    Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer.
    Eur Urol. 2018;73:149-152.
    Abstract     Related articles   

  416. YUH B, Chan K, Wilson T
    Robotic Cystectomy-Moving from Innovation to Measurable Impact.
    Eur Urol. 2018;74:472-473.
    Abstract     Related articles   

  417. ZUIVERLOON TCM, Theodorescu D
    Re: Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.
    Eur Urol. 2019 Jan 17. pii: S0302-2838(18)31024.
    Abstract     Related articles   

  418. CHOUDHURY A, Hoskin PJ
    Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues.
    Eur Urol. 2019 Feb 4. pii: S0302-2838(19)30086.
    Abstract     Related articles   

  419. EFSTATHIOU JA, Mouw KW, Gibb EA, Liu Y, et al
    Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-sparing Trimodality Therapy for Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Jan 31. pii: S0302-2838(19)30012.
    Abstract     Related articles   

  420. BESSA A, Maclennan S, Enting D, Bryan R, et al
    Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method.
    Eur Urol. 2019 Jan 31. pii: S0302-2838(19)30075.
    Abstract     Related articles   

  421. RADZISZEWSKI P, Poletajew S
    Re: Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guerin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-G
    Eur Urol. 2019 Jan 31. pii: S0302-2838(19)30074.
    Abstract     Related articles   

    Bladder Tumors with Mixed Histology: What Is the Basis for the Heterogeneity?
    Eur Urol. 2018;74:754-755.
    Abstract     Related articles   

  423. GOLDSTEIN MR, Mascitelli L
    Re: John L. Gore, Jonathan L. Wright. Can We Prevent Bladder Cancer Recurrences? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.10.008.
    Eur Urol. 2019 Feb 11. pii: S0302-2838(19)30093.
    Abstract     Related articles   

  424. KAMAT AM, Li R, O'Donnell MA, Black PC, et al
    Predicting Response to Intravesical Bacillus Calmette-Guerin Immunotherapy: Are We There Yet? A Systematic Review.
    Eur Urol. 2018;73:738-748.
    Abstract     Related articles   

  425. WITJES JA
    Re: Bladder Preservation with Twice-a-day Radiation plus Fluorouracil/Cisplatin or Once Daily Radiation plus Gemcitabine for Muscle-invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial.
    Eur Urol. 2019 Feb 25. pii: S0302-2838(19)30163.
    Abstract     Related articles   

  426. PICHLER R, Heidegger I
    Re: F. Johannes P. van Valenberg, Andrew M. Hiar, Ellen Wallace, et al. Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.11.055.
    Eur Urol. 2019 Feb 22. pii: S0302-2838(19)30159.
    Abstract     Related articles   

  427. LI R, Spiess PE, Gilbert SM, Necchi A, et al
    Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Mar 1. pii: S0302-2838(19)30174.
    Abstract     Related articles   

  428. NARAYAN VM, Lim AH, Dinney CPN
    Re: Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-sparing Trimodality Therapy for Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Mar 1. pii: S0302-2838(19)30165.
    Abstract     Related articles   

  429. MONTORSI F, Gandaglia G
    Re: Georg Jancke, Firas Aljabery, Sigurdur Gudjonsson, et al. Port-site Metastases After Robot-assisted Radical Cystectomy: Is There a Publication Bias? Eur Urol 2018;73:641-2.
    Eur Urol. 2019;75:e31.
    Abstract     Related articles   

  430. CAMPI R, Roupret M
    Re: Conservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-institutional Cohort Study.
    Eur Urol. 2019 Mar 14. pii: S0302-2838(19)30187.
    Abstract     Related articles   

  431. GAKIS G
    Re: Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial.
    Eur Urol. 2019 Mar 13. pii: S0302-2838(19)30181.
    Abstract     Related articles   

  432. DUGUE PA, Brinkman MT, Hodge AM, Bassett JK, et al
    Dietary intake of nutrients involved in one-carbon metabolism and risk of urothelial cell carcinoma: A prospective cohort study.
    Int J Cancer. 2018;143:298-306.
    Abstract     Related articles   

  433. TURNER MC, Gracia-Lavedan E, Cirac M, Castano-Vinyals G, et al
    Ambient air pollution and incident bladder cancer risk: updated analysis of the Spanish Bladder Cancer Study.
    Int J Cancer. 2019 Jan 17. doi: 10.1002/ijc.32136.
    Abstract     Related articles   

  434. HUANG Z, Zhang M, Chen G, Wang W, et al
    Bladder cancer cells interact with vascular endothelial cells triggering EGFR signals to promote tumor progression.
    Int J Oncol. 2019 Feb 27. doi: 10.3892/ijo.2019.4729.
    Abstract     Related articles   

  435. MIYATA Y, Matsuo T, Sakai H
    Editorial Comment from Dr Miyata et al. to Impact of serum sodium concentration on survival outcomes in patients with invasive bladder cancer without metastasis treated by cystectomy.
    Int J Urol. 2019 Jan 22. doi: 10.1111/iju.13893.
    Abstract     Related articles   

  436. KOIE T, Ohyama C, Makiyama K, Shimazui T, et al
    Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancer.
    Int J Urol. 2019 Jan 28. doi: 10.1111/iju.13900.
    Abstract     Related articles   

  437. TEISHIMA J, Matsubara A
    Editorial Comment to Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancer.
    Int J Urol. 2019 Jan 28. doi: 10.1111/iju.13906.
    Abstract     Related articles   

  438. LEE A, Lee HJ, Huang HH, Ho H, et al
    Low-risk non-muscle-invasive bladder cancer: Further prognostic stratification into the "very-low-risk" group based on tumor size.
    Int J Urol. 2019 Mar 4. doi: 10.1111/iju.13913.
    Abstract     Related articles   

  439. ZACHOS I
    Editorial Comment to Low-risk non-muscle-invasive bladder cancer: Further prognostic stratification into the "very-low-risk" group based on tumor size.
    Int J Urol. 2019 Mar 4. doi: 10.1111/iju.13929.
    Abstract     Related articles   

  440. AMINI E, Ahmadi N, Clifford TG, Hugen CM, et al
    Long term oncologic outcome in patients with bladder cancer after radical cystectomy: Impact of carcinoma in situ in the era of neoadjuvant chemotherapy.
    Int Urol Nephrol. 2019 Jan 31. pii: 10.1007/s11255-019-02087.
    Abstract     Related articles   

  441. TEKE K, Yilmaz H, Uslubas AK, Akpinar G, et al
    Histopathologic and molecular comparative analyses of intravesical Aurora kinase-A inhibitor Alisertib with bacillus Calmette-Guerin on precancerous lesions of bladder in a rat model.
    Int Urol Nephrol. 2018;50:1417-1425.
    Abstract     Related articles   

  442. ZEWIN TS, El-Assmy A, Harraz AM, Bazeed M, et al
    Efficacy and safety of low-intensity shock wave therapy in penile rehabilitation post nerve-sparing radical cystoprostatectomy: a randomized controlled trial.
    Int Urol Nephrol. 2018;50:2007-2014.
    Abstract     Related articles   

  443. ZHANG S
    Neoadjuvant Immunotherapy in Muscle-Invasive Bladder Cancer: Time to Change Clinical Practice?
    J Clin Oncol. 2019 Feb 27:JCO1801864. doi: 10.1200/JCO.18.01864.
    Abstract     Related articles   

  444. ATALA A
    Re: Identification of MicroR-106b as a Prognostic Biomarker of p53-Like Bladder Cancers by ActMiR.
    J Urol. 2019;201:231.
    Abstract     Related articles   

  445. CHANG SS
    Re: Analysis of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens: .
    J Urol. 2019;201:225-226.
    Abstract     Related articles   

  446. EBRAHIMI H, Amini E, Pishgar F, Moghaddam SS, et al
    Global, Regional, and National Burden of Bladder Cancer, 1990 - 2016: Results from the Global Burden of Disease Study 2016.
    J Urol. 2019 Jan 25. doi: 10.1097/JU.0000000000000025.
    Abstract     Related articles   

  447. CHANG SS
    Re: Long-Term Survival Outcomes with Intravesical Nanoparticle Albumin-Bound Paclitaxel for Recurrent Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-Guerin Therapy.
    J Urol. 2019 Jan 15. doi: 10.1097/JU.0000000000000097.
    Abstract     Related articles   

  448. CHANG SS
    Re: Next-Generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.
    J Urol. 2019 Jan 15. doi: 10.1097/01.JU.0000553308.83315.
    Abstract     Related articles   

  449. ATALA A
    Re: LNMAT1 Promotes Lymphatic Metastasis of Bladder Cancer via CCL2 Dependent Macrophage Recruitment.
    J Urol. 2019 Jan 15. doi: 10.1097/01.JU.0000553307.75692.
    Abstract     Related articles   

  450. HAIFLER M
    Editorial Comment.
    J Urol. 2018;200:59-60.
    Abstract     Related articles   

  451. FILSON CP
    Editorial Comment.
    J Urol. 2018;200:59.
    Abstract     Related articles   

  452. MEEKS JJ, Glaser AP
    Editorial Comment.
    J Urol. 2018;200:60.
    Abstract     Related articles   

  453. WANG DS
    Re: A Prospective Randomized Pilot Study Evaluating an ERAS Protocol versus a Standard Protocol for Patients Treated with Radical Cystectomy and Urinary Diversion for Bladder Cancer.
    J Urol. 2019 Feb 1. doi: 10.1097/JU.0000000000000154.
    Abstract     Related articles   

  454. CHANG SS
    Re: Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: .
    J Urol. 2019;201:442.
    Abstract     Related articles   

  455. CHANG SS
    Re: Human Epidermal Growth Factor Receptor 2 Expression is More Important than bacillus Calmette Guerin Treatment in Predicting the Outcome of T1G3 Bladder Cancer.
    J Urol. 2019;201:441-442.
    Abstract     Related articles   

  456. CHANG SS
    Re: Assessing Cancer Progression and Stable Disease after Neoadjuvant Chemotherapy for Organ-Confined Muscle-Invasive Bladder Cancer.
    J Urol. 2019;201:441.
    Abstract     Related articles   

    Re: Impact of Psychiatric Illness on Decreased Survival in Elderly Patients with Bladder Cancer in the United States.
    J Urol. 2019 Feb 7. doi: 10.1097/JU.0000000000000162.
    Abstract     Related articles   

    Re: Comparing Survival Outcomes and Costs Associated with Radical Cystectomy and Trimodal Therapy for Older Adults with Muscle-Invasive Bladder Cancer.
    J Urol. 2019 Feb 7. doi: 10.1097/01.JU.0000553996.66966.
    Abstract     Related articles   

    Re: The Challenges of Bacillus of Calmette-Guerin (BCG) Therapy for High Risk Non Muscle Invasive Bladder Cancer Treatment in Older Patients.
    J Urol. 2019 Feb 7. doi: 10.1097/01.JU.0000553995.59343.
    Abstract     Related articles   

  460. CHANG SS
    Re: Predicting Local Failure after Radical Cystectomy in Patients with Bladder Cancer: .
    J Urol. 2019 Feb 8. doi: 10.1097/JU.0000000000000166.
    Abstract     Related articles   

  461. CHANG SS
    Re: National Comprehensive Cancer Network Recommendations on Molecular Profiling of Advanced Bladder Cancer.
    J Urol. 2019 Feb 8. doi: 10.1097/01.JU.0000554054.35801.
    Abstract     Related articles   

  462. CHANG SS
    Re: Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer.
    J Urol. 2019 Feb 8. doi: 10.1097/01.JU.0000554055.35801.
    Abstract     Related articles   

  463. KIMURA S, Mari A, Foerster B, Abufaraj M, et al
    Prognostic Value of Concomitant Carcinoma In Situ in the Radical Cystectomy Specimen: A Systematic Review and Meta-Analysis.
    J Urol. 2019;201:46-53.
    Abstract     Related articles   

  464. WINTERS BR, Wen L, Holt SK, Dash A, et al
    Does the diagnosis of bladder cancer lead to higher rates of smoking cessation? Findings from the Medicare Health Outcomes Survey.
    J Urol. 2019 Mar 5:101097JU0000000000000206. doi: 10.1097/JU.0000000000000206.
    Abstract     Related articles   

  465. LEO MC, Gilbert SM, Wendel CS, Krouse RS, et al
    Development of a goal elicitation measure to support bladder cancer patients' choice about urinary diversion.
    J Urol. 2019 Mar 5:101097JU0000000000000203. doi: 10.1097/JU.0000000000000203.
    Abstract     Related articles   

  466. CHANG SS
    Re: Safety and Efficacy of Temsirolimus as Second Line Treatment for Patients with Recurrent Bladder Cancer.
    J Urol. 2019 Mar 13:10109701JU000055464194059.
    Abstract     Related articles   

  467. CHANG SS
    Re: Partial Bladder Boost Using Lipiodol Marking during Image-Guided Radiotherapy for Bladder Cancer.
    J Urol. 2019 Mar 13:101097JU0000000000000218. doi: 10.1097/JU.0000000000000218.
    Abstract     Related articles   

    Re: Comparative Safety of Pioglitazone versus Clinically Meaningful Treatment Alternatives Concerning the Risk of Bladder Cancer in Older US Adults with Type 2 Diabetes.
    J Urol. 2019 Mar 13:10109701JU00005546361960937.
    Abstract     Related articles   

    Re: Outcomes of Radiosensitisation in Elderly Patients with Advanced Bladder Cancer.
    J Urol. 2019 Mar 13:10109701JU00005546347386712.
    Abstract     Related articles   

    Re: Real-World Effectiveness of Chemotherapy in Elderly Patients with Metastatic Bladder Cancer in the United States.
    J Urol. 2019 Mar 13:10109701JU0000554635814908.
    Abstract     Related articles   

    Editorial Comment.
    J Urol. 2018;200:290.
    Abstract     Related articles   

  472. PATEL S, Cookson MS
    Editorial Comment.
    J Urol. 2018;200:290-291.
    Abstract     Related articles   

    Re: Stenting Prior to Cystectomy is an Independent Risk Factor for Upper Urinary Tract Recurrence: B. Kiss, M. A. Furrer, P. Y. Wuethrich, F. C. Burkhard, G. N. Thalmann and B. Roth J Urol 2017;198:1263-1268.
    J Urol. 2018;200:457-458.
    Abstract     Related articles   

  474. ZHU J, Huang G, Hua X, Li Y, et al
    CD44s is a crucial ATG7 downstream regulator for stem-like property, invasion, and lung metastasis of human bladder cancer (BC) cells.
    Oncogene. 2019 Jan 11. pii: 10.1038/s41388-018-0664.
    Abstract     Related articles   

  475. CHENG M, Sheng L, Gao Q, Xiong Q, et al
    The m(6)A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-kappaB/MYC signaling network.
    Oncogene. 2019 Jan 18. pii: 10.1038/s41388-019-0683.
    Abstract     Related articles   

  476. ROUDNICKY F, Yoon SY, Poghosyan S, Schwager S, et al
    Alternative transcription of a shorter, non-anti-angiogenic thrombospondin-2 variant in cancer-associated blood vessels.
    Oncogene. 2018;37:2573-2585.
    Abstract     Related articles   

  477. LIU JY, Zeng QH, Cao PG, Xie D, et al
    SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway and predicts poorer survival.
    Oncogene. 2018;37:3937-3952.
    Abstract     Related articles   

  478. LIU Q, Gheorghiu L, Drumm M, Clayman R, et al
    PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53.
    Oncogene. 2018;37:2793-2805.
    Abstract     Related articles   

  479. ZHUO Z, Song Z, Ma Z, Zhang Y, et al
    Chlorophyllin e6mediated photodynamic therapy inhibits proliferation and induces apoptosis in human bladder cancer cells.
    Oncol Rep. 2019 Feb 14. doi: 10.3892/or.2019.7013.
    Abstract     Related articles   

  480. HO JN, Byun SS, Lee SE, Youn JI, et al
    Multikinase inhibitor motesanib enhances the antitumor effect of cisplatin in cisplatinresistant human bladder cancer cells via apoptosis and the PI3K/Akt pathway.
    Oncol Rep. 2019 Feb 11. doi: 10.3892/or.2019.7005.
    Abstract     Related articles   

  481. CHENG H, Hao Y, Gao Y, He Y, et al
    PLCepsilon promotes urinary bladder cancer cells proliferation through STAT3/LDHA pathwaymediated glycolysis.
    Oncol Rep. 2019 Mar 13. doi: 10.3892/or.2019.7056.
    Abstract     Related articles   

  482. SEKINO Y, Sakamoto N, Ishikawa A, Honma R, et al
    Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer.
    Oncol Rep. 2019 Feb 28. doi: 10.3892/or.2019.7039.
    Abstract     Related articles   

  483. HORI S, Miyake M, Tatsumi Y, Morizawa Y, et al
    Intravesical treatment of chemotherapeutic agents sensitizes bacillus CalmetteGuerin by the modulation of the tumor immune environment.
    Oncol Rep. 2019;41:1863-1874.
    Abstract     Related articles   

  484. MARTIN T, Mantey K, Boissier R, Albert P, et al
    [The REVELA13 observatory to study new cases of bladder tumor among women living in Bouches-du-Rhone county].
    Prog Urol. 2018;28:935-941.
    Abstract     Related articles   

  485. BALDINI A, Fassi Fehri H, Cerantola Y, Bayle F, et al
    [Do initial experience with an enhanced recovery program after surgery (ERAS) improve postoperative outcomes after cystectomy?]
    Prog Urol. 2018;28:351-358.
    Abstract     Related articles   

  486. FERRO M, Vartolomei MD, Cantiello F, Lucarelli G, et al
    High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study.
    Urol Int. 2018;101:7-15.
    Abstract     Related articles   

  487. BEN BAHRIA-SEDIKI I, Chebil M, Sampaio C, Martel-Frachet V, et al
    Prognostic Value of Soluble Death Receptor Ligands in Patients with Transitional Cell Carcinoma of Bladder.
    Urol Int. 2018;100:476-484.
    Abstract     Related articles   

  488. GIERTH M, Zeman F, Denzinger S, Vetterlein MW, et al
    Influence of Body Mass Index on Clinical Outcome Parameters, Complication Rate and Survival after Radical Cystectomy: Evidence from a Prospective European Multicentre Study.
    Urol Int. 2018;101:16-24.
    Abstract     Related articles   

  489. GROEBEN C, Koch R, Baunacke M, Borkowetz A, et al
    In-Hospital Outcomes after Radical Cystectomy for Bladder Cancer: Comparing National Trends in the United States and Germany from 2006 to 2014.
    Urol Int. 2019 Jan 30:1-9. doi: 10.1159/000496347.
    Abstract     Related articles   

  490. MOSCHINI M, Zamboni S, Mattei A, Baumeister P, et al
    Radical Cystectomy in Pathological T4a and T4b Bladder Cancer Patients: Is There Any Space for Sub Stratification?
    Urol Int. 2019 Jan 29:1-8. doi: 10.1159/000493899.
    Abstract     Related articles   

  491. CARRION A, Diaz F, Raventos C, Lozano F, et al
    Comparison of Outcomes between Standard and Palliative Management for High Grade Non-Muscle Invasive Bladder Cancer in Patients Older than 85 Years.
    Urol Int. 2019 Mar 7:1-7. doi: 10.1159/000496802.
    Abstract     Related articles   

  492. RAYN KN, Ritchie C, Folio LR, Stamatakis L, et al
    Bilateral Ureteroenteric Strictures: A Case of the "Reverse 7".
    Urology. 2018;118:e3-e4.
    Abstract     Related articles   

  493. BAJIC P, Wolfe AJ, Gupta GN
    The Urinary Microbiome: Implications in Bladder Cancer Pathogenesis and Therapeutics.
    Urology. 2019 Jan 4. pii: S0090-4295(19)30006.
    Abstract     Related articles   

  494. GONZALEZ AN, Lipsky MJ, Li G, Rutman MP, et al
    The prevalence of bladder cancer during cystoscopy for asymptomatic microscopic hematuria.
    Urology. 2019 Jan 21. pii: S0090-4295(19)30073.
    Abstract     Related articles   

  495. LOH-DOYLE JC, Ashrafi A, Nazemi A, Ghodoussipour S, et al
    Dual Prosthetic Implantation After Radical Cystoprostatectomy and Neobladder: Outcomes of the Inflatable Penile Prosthesis and Artificial Urinary Sphincter in Bladder Cancer Survivors.
    Urology. 2019 Jan 18. pii: S0090-4295(19)30065.
    Abstract     Related articles   

  496. GOULET CR, Champagne A, Bernard G, Vandal D, et al
    Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
    BMC Cancer. 2019;19:137.
    Abstract     Related articles   

  497. LV S, Wang W, Wang H, Zhu Y, et al
    PPARgamma activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway.
    BMC Cancer. 2019;19:204.
    Abstract     Related articles   

  498. PANG K, Zhang Z, Hao L, Shi Z, et al
    The ERH gene regulates migration and invasion in 5637 and T24 bladder cancer cells.
    BMC Cancer. 2019;19:225.
    Abstract     Related articles   

  499. YOSHINO T, Miyazaki J, Kojima T, Kandori S, et al
    Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guerin induce antitumor immunity in a syngeneic murine bladder cancer model.
    PLoS One. 2019;14:e0209196.
    Abstract     Related articles   

  500. APOLLO A, Ortenzi V, Scatena C, Zavaglia K, et al
    Molecular characterization of low grade and high grade bladder cancer.
    PLoS One. 2019;14:e0210635.
    Abstract     Related articles   

  501. BYUN SJ, Park W, Cho KH, Cho J, et al
    A multi-institutional study of bladder-preserving therapy for stage II-IV bladder cancer: A Korean Radiation Oncology Group Study (KROG 14-16).
    PLoS One. 2019;14:e0209998.
    Abstract     Related articles   

  502. BOSSCHIETER J, Bach S, Bijnsdorp IV, Segerink LI, et al
    A protocol for urine collection and storage prior to DNA methylation analysis.
    PLoS One. 2018;13:e0200906.
    Abstract     Related articles   

  503. HASNAIN Z, Mason J, Gill K, Miranda G, et al
    Machine learning models for predicting post-cystectomy recurrence and survival in bladder cancer patients.
    PLoS One. 2019;14:e0210976.
    Abstract     Related articles   

  504. SIMON M, Bosset PO, Rouanne M, Benhamou S, et al
    Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk score.
    PLoS One. 2019;14:e0211721.
    Abstract     Related articles   

  505. BAUSCH K, Roth E, Heinz S, Horst D, et al
    Urinary Calprotectin loses specificity as tumour marker due to sterile leukocyturia associated with bladder cancer.
    PLoS One. 2019;14:e0213549.
    Abstract     Related articles   

  506. LU DL, Ren ZJ, Zhang Q, Ren PW, et al
    Meta-analysis of the association between the inflammatory potential of diet and urologic cancer risk.
    PLoS One. 2018;13:e0204845.
    Abstract     Related articles   

  507. LIM YW, Chen-Harris H, Mayba O, Lianoglou S, et al
    Germline genetic polymorphisms influence tumor gene expression and immune cell infiltration.
    Proc Natl Acad Sci U S A. 2018;115:E11701-E11710.
    Abstract     Related articles   

  508. MULLENDERS J, de Jongh E, Brousali A, Roosen M, et al
    Mouse and human urothelial cancer organoids: A tool for bladder cancer research.
    Proc Natl Acad Sci U S A. 2019 Feb 20. pii: 1803595116.
    Abstract     Related articles   

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.